Next Article in Journal
Density Functional Theory Study on Mechanism and Selectivity of Nickel-Catalyzed Hydroboration of Vinylarenes
Previous Article in Journal
Structural Innovations in Vancomycin: Overcoming Resistance and Expanding the Antibacterial Spectrum
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Complementary Synthesis of Anti- and Syn-Hydroxymethyl 1,3-Diols via Regioselective Ring Opening of TIPS-Protected 2,3-Epoxy Alcohols: Toward Polypropionate Fragments

by
Raúl R. Rodríguez-Berríos
* and
José A. Prieto
Department of Chemistry, University of Puerto Rico, Rio Piedras Campus, 17 Ave. Universidad Ste 1701, San Juan, PR 00925-2537, USA
*
Author to whom correspondence should be addressed.
Organics 2025, 6(3), 29; https://doi.org/10.3390/org6030029
Submission received: 21 May 2025 / Revised: 7 July 2025 / Accepted: 9 July 2025 / Published: 10 July 2025

Abstract

Hydroxymethyl 1,3-diol motifs are common structural motifs in natural products, particularly in polypropionates with important therapeutic potential. However, general and complementary methods for their regio- and diastereoselective synthesis remain limited. In this study, we expanded a second-generation epoxide-based methodology involving the regioselective cleavage of TIPS-monoprotected cis- and trans-2,3-epoxy alcohols using alkenyl Grignard reagents. Regioselective ring opening of cis-epoxides provided anti-1,3-diols, while trans-epoxides afforded the corresponding syn-1,3-diols. The use of cis-propenylmagnesium bromide and vinyl Grignard reagents enabled direct access to cis- and terminal homoallylic 1,3-diols, respectively, with moderate to good yields (46–88%) and excellent regioselectivities (95:5). In contrast, reactions with trans-propenyl Grignard reagent led to partial alkene isomerization, limiting their synthetic utility. To address this, a complementary two-step approach employing propynyl alanate addition followed by sodium/ammonia reduction was incorporated, providing access to trans-homoallylic 1,3-diols with high diastereoselectivity. All 1,3-diols were characterized by NMR spectroscopy, confirming regioselective epoxide opening. These combined strategies offer a practical and modular platform for the synthesis of syn- and anti-hydroxymethylated 1,3-diols and their application to the construction of polypropionate-type fragments, supporting future efforts in the total synthesis of polyketide natural products.

1. Introduction

Hydroxymethyl 1,3-diols are structural motifs commonly found in natural products with significant medicinal potential [1,2]. The relative configuration between the primary alcohol (1-hydroxymethyl) and the secondary alcohol (3-hydroxy) can be either anti or syn (Figure 1).
The anti-1,3-diol motif is found in 16-membered macrolide antibiotics such as tylosins [3], mycinamicins (i.e., I, III, and IV) [4,5,6,7,8], aldgamacins [8,9,10], tianchimycin [11], swalpamycin [12,13], and the chalcomycins [14,15], all of which feature a glycosylated C20-primary alcohol (Figure 2). Other macrolides, such as tedanolide [16,17], contain the anti-1,3-diol at C16-C17 and the C29-primary alcohol, whereas scytophycin E contains a syn-1,3-diol with a hydroxymethyl group at C26 [18]. In contrast, the linear polypropionate myriaporones, (e.g., myraporone 4) have syn- and anti-1,3-diol motifs [17,19] (Figure 2), and the ansa chain of streptovaricin D features a functionalized methyl group at C10 [20,21]. Hydroxymethyl 1,3-diols are also present in other types of secondary metabolites such as terpenoids [22,23] and lignans [24,25], among others [26].
To date, few enantio- and stereoselective methods for the synthesis of anti- and syn-hydroxymethyl 1,3-homoallylic diols have been reported. In 2003, a stereoselective cross-metathesis strategy involving the Nozaki–Hiyama reaction, catalyzed by [Cr(Salen)] and functionalized allyl bromides, was reported [27]. This method led to the formation of homoallylic 1,3-diols in moderate yields with good syn-diastereoselectivity (up to 83:17 syn) and enantioselectivity (up to 81% ee). The anti-diastereo- and enantioselective carbonyl (hydroxymethyl) allylation of alcohols or aldehydes catalyzed by an iridium complex was described [28]. From alcohol substrates, good anti-diastereoselectivities (5:1 to 10:1) and excellent enantioselectivities (93–99% ee) were obtained. Similarly, reactions with aldehydes afforded comparable isolated yields (58–74%), anti-diastereoselectivities (4:1 to 14:1 dr), and enantioselectivities (95–99% ee).
The regioselective cleavage of 2,3-epoxy alcohols with carbon nucleophiles to form hydroxymethyl 1,3-diols has been reported using organoaluminum reagents such as Me3Al [29,30], Me2Al–C≡CTMS [29], and Ar3Al [31], as well as organocuprates (e.g., R2CuLi) [32] and lithium acetylides in the presence of BF3·Et2O [33]. These transformations introduce methyl, alkynyl, and aryl groups with varying degrees of regioselectivity.
Our group recently reported a second-generation methodology involving the regioselective cleavage of monoprotected 2,3-epoxy alcohols (1) with alkynylaluminum reagents to synthesize differentially protected homopropargylic hydroxymethyl 1,3- diols (2) (Scheme 1) [34,35]. A key advantage of this substrate-controlled approach is that the enantioenriched 2,3-epoxy alcohols (1), which can be prepared via asymmetric epoxidation, were selectively cleaved at C2 using propynylaluminum ate complexes, affording hydroxymethylated 1,3-homopropargylic diols (2) with high regioselectivity [34]. The diastereoselectivity of the resulting free 1,3-diol unit is syn for trans-epoxides and anti for cis-epoxides (Scheme 1). Subsequent reduction of the alkyne (2) yields complementary homoallylic diols (3), enabling the stereoselective synthesis of C2-syn and C2-anti-epoxy alcohols [35].
Grignard reagents in the presence of copper salts have also been used for regioselective epoxide openings to introduce alkyl and alkenyl groups [36,37]. Our group introduced the use of copper-catalyzed cis- and trans-1-propenyl Grignard reagents to cleave hindered and unprotected epoxides to construct syn/anti polypropionate units (Scheme 2), employing the first-generation methodology [38,39]. Unlike the alkynyl alane approach [40,41,42], this strategy directly installs the alkenyl moiety in the propionate unit, avoiding the need for alkyne cis/trans reduction.
The regioselective opening of benzyl-monoprotected cis- and trans-2,3-epoxy alcohols with Grignard reagents was first reported in 1983 by Tius and Fauq [36] and later in 2001 by Riccardis and co-workers [43]. They employed vinylic Grignard reagents such as CH=CHMgBr and CH2=C(CH3)MgBr in the presence of catalytic CuI to yield regioselective mixtures of homoallylic 1,3-diols and 1,2-diols. Both studies showed consistent results: anti-hydroxymethyl 1,3-diols were obtained with regioselectivities ranging from 72:18 to 83:17, while syn-hydroxymethyl 1,3-diols were obtained with regioselectivities between 80:20 and 84:16. To date, reported reactions with alkenyl Grignard reagents have been limited to monobenzyl-protected 2,3-epoxy alcohols, which exhibit regioselectivities ranging from moderate to good.
Despite these advances, no general and unified methodology currently enables the complementary synthesis of both syn- and anti-hydroxymethyl 1,3-homoallylic diols with high levels of enantio-, regio- and stereocontrol. To address this gap, we expanded our second-generation methodology by employing copper-catalyzed alkenyl Grignard reagents to investigate the regioselective cleavage of TIPS-monoprotected cis- and trans-2,3-epoxy alcohols (1) (Scheme 3).
Herein, we report the asymmetric synthesis of cis- and trans-epoxides (1), to demonstrate the viability of performing this methodology in an enantioenriched form. Although the copper-catalyzed alkenyl Grignard cleavage studies were carried out using racemic epoxides for cost-effectiveness, the development of the methodology did not depend on the use of optically active epoxides. This strategy enables the efficient and stereodivergent synthesis of homoallylic syn- and anti-hydroxymethyl 1,3-diols with excellent regioselectivity and provides a modular platform for the construction of polypropionate-type fragments commonly found in bioactive natural products.

2. Materials and Methods

2.1. General Considerations

All reactions were carried out in oven-dried glassware (overnight, 120 °C) under a nitrogen atmosphere. Standard handling techniques for air-sensitive compounds were employed for all the experiments, i.e., moisture or air sensitive compounds were transferred via syringe or stainless-steel cannulating needles through rubber septa to the glassware, which had previously been flame-dried under reduced pressure three times. All solvents were dried and purified in an MBraun Auto-SPS system before use. All commercially available compounds were used as received, without further purification unless otherwise noted. For the Sharpless asymmetric epoxidation, Ti(iOPr)4 and DIPT tartrate were distilled under reduced pressure prior to use and allylic alcohols 5-Z and 5-E were prepared using a reported procedure [35]. Reactions were monitored by TLC using Sigma Silica Gel 60F (with or without UV indicator) plastic plates (0.25 mm). Components were visualized using ethanolic p-anisaldehyde solution or long-wave UV light. Unless otherwise noted, all products were purified by silica gel column chromatography and fully characterized. One-dimensional and two-dimensional 1H NMR (500 or 300 MHz), 13C NMR (125 or 75 MHz), and 31P (121.5 MHz) spectra were obtained as solutions in deuterochloroform relative to CDCl3 (δ 7.26 and 77.0 for 1H and 13C NMR, respectively). NMR chemical shifts (δ) are given in ppm relative to TMS and coupling constants (J) in Hz. All reactions under microwave irradiation were performed in a CEM Discover 1–300 W system equipped with a built-in pressure measurement sensor and a vertically focused IR sensor (mode Discover Standard) following the general procedure. Optical rotations were measured employing a Rudolph Research Analytical polarimeter. Elemental analyses were performed by Atlantic Microlab, Inc. Norcross, GA, USA. Reported atomic percentages are within error limits of +0.4% as required by ACS journals.

2.2. General Synthetic Procedures

2.2.1. General Procedure A for the Synthesis of Optically Active Epoxy Alcohols via Sharpless Asymmetric Epoxidation

To a dry round-bottom flask containing activated powdered 4Å molecular sieves (50–60% w/w, previously heated overnight under reduced pressure to remove moisture) was added dry CH2Cl2 (0.2 M) and cooled to around −20 to −40 °C. Then, freshly distilled Ti(iOPr)4 (1.0 equiv) and L-DIPT (1.2 equiv) were added. A TBHP solution (3 equiv) was then added. The solution was stirred at −20 to −40 °C for 30 min. The allylic alcohol (1 equiv) was then added, and the reaction mixture was stirred at −20 °C for 24 h. The reaction was placed in a −10 °C freezer for approximately 24–48 h until the TLC analysis indicated no remaining allylic alcohol. The reaction was vigorously stirred and quenched with water. The mixture was allowed to warm to room temperature and stirred for 1 h. A solution of 30% NaOH in brine was then added and stirred for an additional 30 min. The resulting emulsion was diluted in hexane and filtered through a pad of celite. After the filtrate had separated into two layers, the aqueous phase was extracted with hexane (3 times). The combined organic layer was dried over MgSO4 and concentrated at reduced pressure. The crude product was purified by flash chromatography or distillation under reduced pressure to yield the pure optically active epoxide.

2.2.2. General Procedure B for the Epoxidation of Alkenes with Meta-Chloroperoxybenzoic Acid (m-CPBA) for the Synthesis of Racemic Epoxides

The allylic alcohol was dissolved in DCM (0.1 M) in a round-bottom flask. Then, m-CPBA (2 equiv) and a 0.5 M NaHCO3 solution (0.3 M) were added. The reaction progress was monitored by TLC. When it was completed, the mixture was diluted with hexane and a saturated NaHCO3 solution. The aqueous phase was extracted with hexane. The combined organic phase was washed twice with a 5% NaHSO3 solution, then with saturated NaHCO3 solution and brine. After drying over MgSO4, the solvent was removed under reduced pressure.

2.2.3. General Procedure C for the Microwave-Assisted VO(acac)2-Catalyzed Epoxidation of Alkenols with TBHP

VO(acac)2 0.014 equiv was added to a reaction tube followed by toluene (0.083 M), the alkenol 0.24 mmol, and TBHP (1.1 equiv). Microwave irradiation (150 W maximum) was applied for a temperature of 113 °C. The reaction was judged complete using TLC. After the irradiation period, the reaction was cooled to room temperature (approx. 20 min). The crude product mixture was diluted with saturated Na2S2O3, the aqueous phase was extracted with hexane (3 times). The combined organic phase was dried under anhydrous MgSO4 and, finally, concentrated under reduced pressure.

2.2.4. General Procedure D for the Copper-Catalyzed Cleavage of Epoxides Using Alkenylmagnesium Bromides

Mg powder (14.4 equiv) was added to a round bottom flask assembled with a dry ice condenser. Freshly distilled THF (2.3 M with respect to Mg) was added to the flask and spiked with I2. After several minutes, the reaction mixture turned from yellow to turbid gray. Then, the dry ice condenser was cooled to −78 °C and alkenyl bromide (6 equiv) was added. After several minutes, the reaction was warmed and refluxed vigorously. The reaction was stirred for 1 h. The solution was transferred via a double-ended needle to a three-necked round bottom flask containing CuI (0.1 or 1.35 equiv) in ether (0.04 M) at −78 °C. The CuI had previously been heated overnight under reduced pressure to remove moisture. After 30 min, the epoxide was added at −78 °C. The reaction mixture was allowed to reach room temperature and stirred overnight. At this point, the reaction was quenched with a saturated solution of NH4Cl (26 mL) and diluted in ether. The layers were separated, and the aqueous phase was extracted with ether. The combined organic phase was dried over MgSO4, filtered through Celite pad, and concentrated under reduced pressure.

2.2.5. General Procedure E for the Alkynyl Substitution Reaction of Epoxy Alcohols (Alane Ate Procedure)

Following the procedure of Miyashita with some modifications [29], a three-neck round-bottom flask, equipped with a dry ice condenser, was charged with dry toluene (0.3 M) via syringe and the system was cooled to 0 °C. Then, n-BuLi was added to the reaction flask and TMS-acetylene was added via syringe or an excess of propine gas was bubbled, and the reaction turned milky white. After 30 min, Et2AlCl was added via syringe and the solution was stirred for 4 h. Then, the mixture was cooled at −78 °C, followed by the addition of a solution of lithium alkoxide via a double-ended needle, which had been previously prepared from epoxy alcohol in toluene (0.15 M) and n-BuLi (1.1 equiv) at 0 °C for 30 min. The reaction was allowed to reach room temperature while stirring overnight. The reaction was quenched at 0 °C adding a 5% H2SO4 solution dropwise. The phases were separated, and the aqueous layer was extracted with three portions of hexane. The combined organic layer was dried over MgSO4 and concentrated under reduced pressure.

2.2.6. General Procedure F for the trans Reduction of Alkynes with Na°/NH3

The desired volume of liquid ammonia (0.08 M) was condensed into a round-bottom flask equipped with a dry-ice condenser and containing several Na° cubes (previously washed with hexane), which was partially immersed in a dry ice/acetone bath. Then, the ammonia was distilled into another flask similarly set through a double-ended needle or tygon line. The second flask contained ten equivalents of Na°. A solution of the alkyne in THF (0.4 M) and t-BuOH (1.2 equiv) was added dropwise through an addition funnel. The reaction mixture was allowed to reach room temperature while stirring overnight. The excess Na° was destroyed under an inert atmosphere with methanol, which was very carefully added. The solvent was removed under reduced pressure and the crude was dissolved in water and hexane. Then, the pH was neutralized with H2SO4, followed by the extraction of the aqueous phase with three portions of hexane. The combined organic phase was dried over MgSO4 and concentrated by rotoevaporation.

2.2.7. General Procedure G for the Formation of Acetonides

A round-bottom flask containing the diol at 0 °C was charged with CH2Cl2 (0.1–0.3 M), PPTS (0.06 equiv), and 2-methoxypropene (3–5 equiv). The reaction was followed by TLC. When it was completed, the solvent was removed under reduced pressure. The crude was dissolved in hexane and filtered through a bed of celite. The hexane was then rotoevaporated.

2.2.8. General Procedure H for the Protection of Alcohols with TES-OTf

Dry DMF or DCM (0.35 M), dry DIEA or TEA (1.1–3.0 equiv), and the alcohol were combined into a flamed-dried round bottom flask at room temperature. After 30 min, the silylating reagent (1.1–3.0 equiv) was injected via syringe. The reaction mixture was monitored by TLC. When completed, the reaction was quenched by the addition of water and hexane (same volume as DMF or DCM). The aqueous phase was then extracted with three portions of hexane. The combined organic phase was dried under anhydrous MgSO4 and finally concentrated under reduced pressure.

2.2.9. General Pro2cedure I for the Selective Deprotection of the 1° TES Silyl Ether in the Presence of a 2° TBS Ether

To a flask equipped with a reflux column, the bis-TES ether dissolved in THF (0.2 M) was added. To the mixture, a solution (2:1) containing HOAc (1 M) and water (2 M) was slowly added. After 10 min, the reaction was refluxed for several (3–8) hours. After disappearance of the starting material (TLC), the reaction was cooled to 0 °C and poured slowly into a suspension of NaHCO3 in water (2 M). It was diluted with EtOAc, followed by the extraction of the aqueous phase with EtOAc (3 × 10 mL). The combined organic layers were dried over MgSO4 and concentrated under reduced pressure.

2.3. Experimental and Characterization Data

2.3.1. Preparation of (-)-(2S,3R)-4-(triisopropylsilyloxy)-2-3-epoxy-1-butanol ((-)-1-cis

Following general procedure A, 4Å molecular sieves (0.18 g, 60% w/w), dry CH2Cl2 (7.0 mL, 0.18 M), Ti(iOPr)4 (0.37 mL, 1.2 mmol, 1.0 equiv), L-DIPT (0.26 mL, 1.2 mmol, 1.2 equiv), TBHP (1.0 mL of a 3.80 M solution in toluene, 3.68 mmol, 3.0 equiv), and allylic alcohol 5-Z (0.3 g, 1.2 mmol) were used. After work up and concentration, the crude product was purified by flash chromatography 4:1 (hexane/ethyl acetate) to yield 0.27 g (83%) of the pure epoxide (-)-1-cis as a viscous oil, 80% ee was determined by 31P NMR analysis with the Alexakis method [44]. [ α ] D 20 = 9.9 , (c = 1.02, CHCl3); 1H NMR (CDCl3) δ 4.03 (dd, J = 11.5, 5.0 Hz, 1H), 3.83 (m, J = 10.0, 6.0 Hz, 1H), 3.79 (dd, J = 10.0, 5.7 Hz, 1H), 3.76 (dd, J = 11.5, 5.5 Hz, 1H), 3.24 (ddd, J = 5.5, 5.5. 5.0 Hz, 1H), 3.25 (ddd, J = 6.0, 5.7, 5.5 Hz, 1H), 2.20 (bs, 1H), 1.08 (m, 21H). 13C NMR (CDCl3) δ 61.9, 60.0, 56.3, 55.9, 17.8, 11.8. Derivative: 31P NMR (121.5 MHz, CDCl3) δ 142.3 (12%), 139.2 (88%). Anal. calcd. for C13H28O3Si C, 59.95, H, 10.84. Found: C, 60.00; H, 10.86.

2.3.2. Preparation of (+)-(2R,3S)-4-(triisopropylsilyloxy)-2-3-epoxy-1-butanol (+)-1-cis

Following general procedure A, 4Å molecular sieves (0.18 g, 60% w/w), dry CH2Cl2 (7.0 mL, 0.18 M), Ti(iOPr)4 (0.37 mL, 1.2 mmol, 1.0 equiv), D-DIPT (0.26 mL, 1.2 mmol, 1.2 equiv), and TBHP solution (1.0 mL of a 3.80 M solution in toluene, 3.68 mmol, 3.0 equiv) were reacted with the allylic alcohol 5-E (0.3 g, 1.2 mmol). After work up, solvent evaporation and flash column chromatography (4:1 hexane/ethyl acetate), 0.25 g (80%) of the pure epoxide (+)-1-cis was obtained as a viscous oil, 80% ee was determined by 31P NMR analysis with the Alexakis method [44]. [ α ] D 20 = + 8.4 (c = 1.10, CHCl3); 31P NMR (121.5 MHz, CDCl3) δ 142.3 (10%), 139.2 (90%). Anal. calcd. for C13H28O3Si C, 59.95, H, 10.84. Found: C, 59.81; H, 10.95. Other spectroscopic data are essentially identical to (-)-1-cis.

2.3.3. Preparation of (-)-(2S,3S)-4-(triisopropylsilyloxy)-2-3-epoxy-1-butanol (-)-1-trans

Following the general procedure A, 4Å molecular sieves (0.29 g), dry CH2Cl2 (9.3 mL, 0.22 M), Ti(iOPr)4 (0.41 mL, 1.35 mmol, 0.66 equiv), L-DIPT (0.31 mL, 1.47 mmol, 0.72 equiv), and TBHP solution (2.15 mL of a 3.80 M solution in toluene, 8.18 mmol, 4.0 equiv) were reacted with the allylic alcohol 5-E (0.5 g, 2.1 mmol). After work up, solvent evaporation and purification by Flash chromatography (4:1 hexane/ethyl acetate), 0.3 g (52%) of pure epoxide (-)-1-trans as a viscous oil was obtained. [ α ] D 20 = 10.9 (c = 1.00, CHCl3). Other spectroscopic data are essentially identical to (+)-1-trans.

2.3.4. Preparation of (+)-(2R,3R)-4-(triisopropylsilyloxy)-2-3-epoxy-1-butanol (+)-1-trans

Following the general procedure A, 4Å molecular sieves (12.3 g, 60% w/w), dry CH2Cl2 (93.0 mL, 0.22 M), Ti(iOPr)4 (4.1 mL, 13.5 mmol, 0.66 equiv), D-DIPT (3.5 mL, 14.7 mmol, 0.72 equiv), and TBHP solution (20.1 mL of a 4.07 M solution in toluene, 81.8 mmol, 4.0 equiv) were reacted with the allylic alcohol 5-E (5.0 g, 20.5 mmol). After work up, solvent evaporation and purification by fractional distillation, 3.9 g (80%, Bp = 156 °C/0.1 mmHg) of pure epoxide (+)-1-trans as a viscous oil with 94% ee, determined by 31P NMR analysis with the Alexakis method [44]. [ α ] D 20 = + 13.9 (c = 1.12, CHCl3); 1H NMR (CDCl3) δ 3.97 (dd, J = 12.8, 1.9 Hz, 1H, 3.96 (dd, J = 11.7, 2.4 Hz, 1H) 3.80 (dd, J = 11.7, 4.0 Hz, 1H), 3.65 (dd, J = 12.8, 4.0 Hz, 1H), 3.17 (m, 2H), 1.06 (m, 21H). 13C NMR (CDCl3): δ 62.7, 61.3, 56.1, 55.8, 17.9, 11.9. Anal. Calcd. for C13H28O3Si C, 59.95; H, 10.84. Found: C 59.80; H, 10.98. 31P NMR (121.5 MHz, CDCl3) δ 143.2 (3%), 141.5 (97%).

2.3.5. Preparation of (±)-(2R,3S)-4-(triisopropylsilyloxy)-2,3-epoxy-1-butanol (1-cis)

Following general procedure B, 10.0 g (40.9 mmol) of alkenol 5-Z, 410.0 mL of CH2Cl2, 8.48 g (49.1 mmol) of m-CPBA, and 138.0 mL of 0.5 M NaHCO3 solution were used. After work up, solvent evaporation, and purification by fractional distillation under reduced pressure (bp 110–135 °C/1.6 mmHg), 8.8 g (82%) of the pure racemic epoxide 1-cis was obtained as a viscous oil. The spectroscopic data are essentially identical to (-)-1-cis and (+)-1-cis, as well as to the data reported in reference [35].

2.3.6. Preparation of (±)-(2S,3S)-4-(triisopropylsilyloxy)-2,3-epoxy-1-butanol (1-trans)

Following general procedure B, to a flask containing 5.0 g (17.5 mmol) of alkenol 5-E dissolved in 205.0 mL of CH2Cl2, 4.3 g (24.6 mmol) of m-CPBA slowly and stirred until it dissolved, followed by the addition of 70.0 mL of a 0.5 M NaHCO3 solution. The reaction was stirred overnight. Work up and solvent evaporation yielded 5.0 g (95%) of crude as a viscous oil. The racemic epoxide 1-trans was used for the next step, without further purification. Anal. Calcd for C13H28O3Si C, 59.95; H, 10.84. Found: C 59.63; H, 10.79. The spectroscopic data are essentially identical to (-)-1-trans and (+)-1-trans, as well as to the data reported in reference [35].

2.3.7. Preparation of (±)-(2S,3R)-2-((Z)-prop-1-enyl)-4-(triisopropylsilyloxy)butane-1,3-diol (3a)

Following general procedure D, 1.3 g of Mg powder (23.0 mmol, 14.4 equiv), 25.0 mL of THF, cis-1-bromopropene 2.0 mL (23.0 mmol, 6.0 equiv), 1.0 g CuI (5.2 mmol, 1.35 equiv), 130.0 mL of ether (0.04 M), and epoxide 1-cis (1.0 g, 3.8 mmol) were used. Work up and flash chromatography (4:1 hexane/ethyl acetate) yielded 0.76 g (66%) of alkenol 6a as a viscous oil, obtained as a 96:4 mixture of regioisomers. 1H NMR (CDCl3): δ 5.72 (dq, J = 10.5, 6.9 Hz, 1H), 5.45 (dd, J = 10.5, 10.5 Hz, 1H), 3.88 (ddd, J = 7.0, 4.0, 2.5 Hz, 1H,), 3.73 (dd, J = 10.5, 5.8 Hz, 1H), 3.66 (dd, J = 10.5, 5.2 Hz, 1H), 3.65 (dd, J = 12.0, 2.2 Hz, 1H), 3.62 (dd, J = 12.0, 7.0 Hz, 1H), 2.76 (dddd, J = 10.5, 5.8, 5.2, 4.0 Hz, 1H),2.70 (s, 1H), 2.50 (s, 1H), 1.64 (d, J = 6.9 Hz, 3H), 1.07 (m, 21H). 13C NMR (CDCl3): δ 128.1, 127.1, 73.2, 65.5, 64.5 41.5), 17.9 (-), 13.3, 11.8. Anal. Calcd. for C16H34O3Si: C, 63.52; H, 11.33. Found: C 63.55; H, 11.31. The spectroscopic data are essentially identical to the data reported in reference [35].

2.3.8. Preparation of (±)-(2R,3R)-2-[(Z)-1-propenyl]-4-[(triisopropylsilyl)oxy]-1,3-butanediol (3b)

Following general procedure D, Mg powder (6.73 g, 115.19 mmol, 14.4 eq.), THF (123 mL), cis-1-bromopropene (9.8 mL, 2.35 mmol, 6 equiv), CuI (0.37 g, 1.92 mmol, 0.1 equiv) in ether (48 mL), and epoxide 1-trans (5.0 g, 19.2 mmol) were used. After work up and flash chromatography (Alumina, 4:1 Hexane/EtOAc), 4.93 g (85%) of pure product 3b was obtained as a viscous oil. 1H NMR (CDCl3) δ 5.63 (dqd, J = 11.4, 6.9, 0.42 Hz, 1H), 5.10 (m, 1H), 3.80 (dd, J = 9.4, 6.7 Hz, 1H) 3.73 (dd, J = 9.4, 3.2 Hz, 1H), 3.66 (ddd, J = 9.6, 6.7, 3.2 Hz, 1H), 3.57 (dd, J = 10.9, 4.8 Hz, 1H), 3.50 (dd, J = 9.4, 6.7 Hz, 1H), 2.90 (s, 2H), 2.73 (m, 1H), 1.65 (dd, J = 6.9, 1.8 Hz, 3H), 1.05 (21H,). 13C NMR (CDCl3) δ 128.8, 126.6, 75.4, 65.8, 65.9, 41.9, 17.9, 13.5, 11.8. IR (neat, cm−1) 3372 (OH), 2941–2865 (CH), 1659 (=C), 1064, 1013 (C-O), 881 (Si-C), 680 (CH=CH). Anal. Calcd. for C16H34O3Si: C, 63.52; H, 11.33. Found C, 63.19; H, 11.34. The spectroscopic data are essentially identical to the data reported in reference [38].

2.3.9. Preparation of (±)-(2R,3S)-2-((E)-prop-1-enyl)-4-(triisopropylsilyloxy)butane-1,3-diol (3c)

Following the general procedure D, Mg powder (6.73 g, 276.48 mmol, 14.4 equiv.), THF (123 mL), trans-1-bromopropene (0.6 mL, 6.9 mmol, 6.0 equiv), CuI (0.3 g, 1.8 mmol, 1.35 equiv) in ether (40.0 mL), and epoxide 1-cis (0.30 g, 1.15 mmol) were used. After work up and flash chromatography (1:1 Hexane/Ether), 0.15 g (42%) of an inseparable 66:34 trans/cis mixture of products 6c and 6a was obtained as a viscous oil.
Compound 3c was synthesized as mayor product using a two-step cleavage–reduction sequence, involving propynyl alane-mediated epoxide opening (General procedure D), followed by trans reduction with Na0/NH3 (General procedure F). The spectroscopic data are essentially identical to that reported in references [34,35] and the synthesis is described in Section 2.3.17.

2.3.10. Preparation of (±)-(2R,3R)-2-((E)-prop-1-enyl)-4-(triisopropylsilyloxy)butane-1,3-diol (3d)

Following general procedure D, Mg powder (0.41 g, 16.56 mmol, 14.0 equiv.), THF (7.4 mL), trans-1-bromopropene (0.6 mL, 6.9 mmol, 6.0 equiv), CuI (0.3 g, 1.80 mmol, 1.35 equiv) in ether (40.0 mL), and epoxide 1-tras (0.30 g, 1.15 mmol) were used. After work up and flash chromatography (1:1 Hexane/Ether), 0.22 g (63%) of an inseparable 63:37 trans/cis mixture of products 3d and 3b was obtained as a viscous oil. Compound 3d was synthesized as major product using a two-step cleavage–reduction sequence, involving propynyl alane-mediated epoxide opening (General procedure D), followed by trans reduction with Na0/NH3 (General procedure F). The spectroscopic data are essentially identical to reported in references [34,35], and the synthesis is described in Section 2.3.18.

2.3.11. Preparation of (±)-(2R,3S)-4-(triisopropylsilyloxy)-2-vinyl)butane-1,3-diol (3e)

Following general procedure D, 0.037 g (0.19 mmol, 0.1 equiv) of copper iodide, 5 mL (0.04 M) of ethyl ether, 11.5 mL (11.5 mmol, 6.0 equiv) of vinylmagnesium bromide, and 0.5 g (1.9 mmol, 1.0 equiv) of epoxide 1-cis were used. After work up and flash chromatography (9:1 Hexane/EtOAc), 0.45 g (81%) of the desired product 6e was yielded as a viscous oil. 1H NMR (500 MHz, CDCl3): δ 5.89 (ddd, J = 17.8, 9.1, 8.6 Hz, 1H), 5.20 (dd, J = 17.2, 10.4. Hz, 2H), 3.88 (m, 1H) 3.76 (m, 2H), 3.66 (m, 2H), 2.54 (s, 1H), 2.38 (m, 1H), 2.33 (m, 1H), 1.10 (m, 21H). 13C NMR (125 MHz, CDCl3): δ 134.8, 118.6, 72.6, 65.5), 64.2, 48.4, 17.9, 11.9.

2.3.12. Preparation of (±)-(2R,3R)-4-(triisopropylsilyloxy)-2-vinyl)butane-1,3-diol (3f)

Following general procedure D, 0.02 g (0.11 mmol, 0.1 equiv) of copper iodide, 29 mL (0.04 M) of ethyl ether, 6.9 mL (6.9 mmol, 6.0 equiv) of vinylmagnesium bromide, and 0.3 g (1.15 mmol, 1.0 equiv) of epoxide 1-trans were used. After work up and flash chromatography (6:1 Hexane/EtOAc), 0.17 g (51%) of the desired product 6f was yielded as a viscous oil. 1H NMR (500 MHz, CDCl3): δ 5.62 (ddd, J = 18.3, 9.5, 8.6 Hz, 1H), 5.17 (dd, J = 18.3, 9.5 Hz, 2H), 3.86 (dd, J = 10.7, 7.2 Hz, 1H), 3.77 (m, 1H), 3.73 (m, 1H), 3.68 (dd, J = 10.7, 4.6 Hz, 1H), 3.57 (dd, J = 8.6, 7.8 Hz, 1H), 2.93 (s, 1H), 2.86 (s, 1H), 2.38 (dddd, J = 8.6, 8.6, 6.2, 6.0 Hz, 1H), 1.08 (m, 21H,). 13C NMR (125 MHz, CDCl3): d 135.3, 118.5, 74.3, 65.8, 65.4, 41.8, 17.9, 11.9. The spectroscopic data are essentially identical to that reported in reference [45].

2.3.13. Preparation of (±)-(2R,3S)-4-(triisopropylsilyloxy)-2-(1-(trimethylsilyl)vinyl)butane-1,3-diol (3g)

Following general procedure D, Mg powder (0.39 g, 16.1 mmol, 14.0 equiv), 7.1 mL (2.27 M for Mg) of THF, 1-bromovinyl-1-trimethylsilane (1.1 mL, 6.9 mmol, 6.0 equiv), CuI (0.022 g, 0.115 mmol, 0.1 equiv) in ether (2.9 mL, 0.04 M for CuI), and 0.30 g (1.15 mmol) of epoxide 1-cis were used. After work up and flash chromatography (6:1 hexane/EtOAc), 0.23 g (54%) of pure product 3g was obtained as a viscous oil. 1H NMR (500 MHz, CDCl3) δ 5.82 (s, 1H), 5.63 (s, 1H), 3.92 (m, J = 6.0 Hz, 1H), 3.79–3.70 (m, 3H), 3.62 (dt, J = 11.4, 5.8 Hz, 1H), 2.73 (t, J = 5.7 Hz, 1H), 2.67 (m, J = 12.2, 6.4 Hz, 1H), 2.50 (s, 1H), 1.09 (m, 21H,), 0.11 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 150.2, 127.8, 72.9, 65.7, 63.5, 49.7, 17.9, 11.8, −1.37. Anal. Calcd. for C18H40O3Si2: C, 59.94; H, 11.18. Found: C, 60.03; H, 11.25.

2.3.14. Preparation of (±)-(2R,3R)-4-(triisopropylsilyloxy)-2-(1-(trimethylsilyl)vinyl)butane-1,3-diol (3h)

Following general procedure D, Mg powder (0.39 g, 16.10 mmol, 14.0 equiv), 7.1 mL (2.27 M for Mg) of THF, 1-bromovinyl-1-trimethylsilane (1.1 mL, 6.9 mmol, 6.0 equiv), CuI (0.022 g, 0.115 mmol, 0.1 equiv) in ether (2.9 mL, 0.04 M for CuI), and 0.30 g (1.15 mmol) epoxide 1-trans were used. After work up and flash chromatography (6:1 hexane/EtOAc), 0.19 g (46%) of pure product 3 h was obtained as a viscous oil. 1H NMR (500 MHz, CDCl3) δ 5.66 (s, 1H), 5.50 (s, 1H), 4.00 (ddd, J = 9.0, 8.2, 2.85 Hz, 1H), 3.77 (m, J = 10.0, 2.0 Hz, 1H) 3.74 (m, J = 9.4, 8.0, 2.9 Hz,1H), 3.54 (dd, J = 11.0, 10.0 Hz, 1H), 3.37 (dd, J = 9.4, 8.0 Hz, 1H), 2.43 (ddd, J = 9.0, 8.0,2.9 Hz, 1H), 1.06 (m, 21H), 0.08 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 149.6, 126.5, 76.6, 66.8, 66.3, 47.5, 17.9, 11.8, −1.70. Anal. Calcd. for C18H40O3Si2: C, 59.94; H, 11.18. Found: C, 59.75; H, 11.25.

2.3.15. Preparation of (±)-(2R,3S)-2-(prop-1-ynyl)-4-(triisopropylsilyloxy)butane-1,3-diol (2a) and the minor product (±)-(2R,3S)-3-((triisopropylsilyloxy)methyl)hex-4-yne-1,2-diol (6)

Following general procedure E, 213.0 mL of dry toluene (0.3 M), 25.9 mL (63.8 mmol 4.0 equiv) of n-BuLi (2.46 M in hexane), propyne gas, and 35.4 mL (63.8 mmol, 4.0 equiv) of Et2AlCl (1.8 M in toluene) were added to a round bottom flask. Followed by the addition of a previously prepared solution of 4.15 g (15.9 mmol) of epoxy alcohol 1-cis in 106.0 mL of toluene (0.15 M) and 7.1 mL (17.5 mmol, 1.1 equiv) of n-BuLi (2.46 M in hexanes). After work up and solvent evaporation, 4.62 g (96%) of a 90:10 mixture of regioisomers 2a and 6 was obtained as a viscous oil. This mixture of products was used for the next step, without further purification. 1H NMR (CDCl3) δ 3.83 (m, J = 7.0, 5.0, 4.5 Hz), 3.81 (m, J = 15.0, 3.0 Hz, 2H), 3.78 (dd, J = 15.0, 2.0 Hz, 1H), 3.75 (dd, J = 9.0, 4.5 Hz, 1H), 2.81 (m, J = 5.0, 3.0, 2.0 Hz, 1H,), 2.64 (bs, 1H), 2.38 (bs, 1H), 1.83 (d, J = 3.0 Hz, 3H), 1.07 (m, 21H). 13C NMR (CDCl3) δ 80.7, 75.1, 72.0, 65.3, 63.8, 38.0, 17.9, 11.8, 3.6. Anal. Calcd. for C16H32O3Si: C, 63.95; H, 10.73. Found: C 63.74; H, 10.78.
Spectral data for the minor isomer (±)-(2R,3S)-3-((triisopropylsilyloxy)methyl)hex-4-yne-1,2-diol (6): 1H NMR (CDCl3) δ 3.92 (ddd, J = 6.7, 3.3, 3.2 Hz, 1H), 3.88 (dd, J = 12. 0, 6.0 Hz, 2H), 3.77 (dd, J = 11.3, 6.7 Hz, 1H), 3.67 (dd, J = 11.3, 3.2 Hz, 1H), 2.80, (bs, 1H), 2.69 (ddd, J = 6.7, 3.3, 3.2 Hz, 1H), 2.40 (bs, 1H), 1.83 (d, J = 2.4 Hz, 3H), 1.07 (m, 21H). 13C NMR (CDCl3) δ 80.7, 75.3, 71.4, 65.1, 64.2, 38.0, 17.9, 11.8, 3.5. Anal. Calcd. for C16H32O3Si: C, 63.95; H, 10.73. Found: C 63.38, H, 10.95. The spectroscopic data for regioisomers 2a and 6 are essentially identical to the data reported in reference [34,35].

2.3.16. Preparation of (±)-(2R,3R)-2-(prop-1-ynyl)-4-(triisopropylsilyloxy)butane-1,3-diol (2b) and the minor product (±)-(2S,3S)-3-((triisopropylsilyloxy)methyl)hex-4-yne-1,2-diol

Following general procedure E, 384.0 mL of dry toluene (0.3 M), 48.0 mL (115.2 mmol, 6.0 equiv) of n-BuLi (2.40 M in hexane), an excess of propyne gas, and 64.0 mL (115.2 mmol, 6.0 equiv) of Et2AlCl (1.8 M in toluene) were added to a round bottom flask. Followed by the addition of a previously prepared solution of 5.0 g (19.2 mmol) of the epoxy alcohol (±)-1-trans in 130 mL of toluene (0.15 M) and 8.8 mL (21.1 mmol, 1.1 equiv) of n-BuLi (2.40 M in hexanes). After work up and solvent evaporation, 5.3 g (91%) of neat crude was obtained as a viscous oil. The alkyne diol 2b as an 80:20 mixture of regioisomers was used for the next step without further purification. 1H NMR (CDCl3) δ 3.93 (dd, J = 10.0, 2.0 Hz, 2H), 3.81 (dd, J = 10.0, 3.0 Hz, 1H), 3.79 (dd, J = 10.0, 2.0 Hz, 1H), 3.78 (dd, J = 10.0, 1.5 Hz, 1H), 3.72 (ddd, J = 3.5, 2.0, 2.0 Hz), 2.87 (d, J = 5.0 Hz, 1H), 2.82 (t, J = 5.5 Hz, 1H), 2.65 (ddd, J = 3.5, 3.0, 1.5 Hz, 1H), 1.78 (s, 3H), 1.07 (m, 21H). 13C NMR (CDCl3) δ 80.3, 75.8, 73.2, 65.6, 64.4, 37.5, 17.9, 11.8, 3.5. Anal. Calcd. for C16H32O3Si: C, 63.95; H, 10.73. Found: C 63.66; H, 10.96. The spectroscopic data for mayor regioisomer 2a and its minor regiosisomer are essentially identical to the data reported in reference [34,35].

2.3.17. Preparation of (±)-(2R,3S)-2-((E)-prop-1-enyl)-4-(triisopropylsilyloxy)butane-1,3-diol (3c)

Following general procedure F, liquid ammonia (200 mL), 3.5 g (154.0 mmol) of Na°, 4.6 g (15.4 mmol) of the alkyne 2a in 42.0 mL of THF, and 5.1 mL (62.0 mmol) of t-BuOH were used. After work up, solvent evaporation, and column chromatography (4:1 hexane/ethyl acetate), 2.9 g (62%) of the alkene diol 3c as a viscous oil was obtained for two consecutive steps. 1H NMR (CDCl3): δ 5.60 (dq, J = 15.5, 6.1 Hz, 1H), 5.49 (dd, J = 15.5, 10.3 Hz, 1H), 3.82 (ddd, J = 9.0, 5.0, 2.2 Hz, 1H), 3.72 (dd, J = 20.0, 4.0 Hz, 1H), 3.70 (dd, J = 20.0, 2.5 Hz, 1H), 3.67 (dd, J = 15.3, 2.2 Hz, 1H), 3.65 (dd, J = 15.3, 9.0 Hz, 1H), 2.59 (s, 1H), 2.34 (m, J = 10.3, 5.0, 4.0, 2.5 Hz, 1H), 2.24 (t, J = 6.33 Hz, 1H), 1.72 (d, J = 6.0 Hz, 3H), 1.07 (m, 21H). 13C NMR (CDCl3) δ 129.6, 127.2, 73.0, 65.6, 64.6, 47.7, 18.2, 17.9, 11.8. Anal. Calcd for C16H34O3Si: C, 63.52; H, 11.33. Found: C 63.48; H, 11.33.

2.3.18. Preparation of (±)-(2R,3R)-2-((E)-prop-1-enyl)-4-(triisopropylsilyloxy)butane-1,3-diol (3d)

Following general procedure E, liquid ammonia (220 mL) 10.5 g (456 mmol) of Na°, 5.27 g (17.5 mmol) of the alkyne 2b in 47 mL of THF and 11.6 mL (140.3 mmol) of t-BuOH were added after column chromatography (4:1 hexane/ethyl acetate) to yield 2.81 g (53%) of alkene diol 3d as a viscous oil for three consecutive steps. 1H NMR (CDCl3): δ 5.59 (dq, J = 13.0, 6.4 Hz, 1H), 5.20 (dd, J = 13.3, 9.2 Hz, 1H), 3.81 (ddd, J = 6.0, 6.0, 2.0 Hz, 1H), 3.75 (dd, J = 10.0, 2.0 Hz, 1H), 3.66 (dd, J = 10.0, 6.0 Hz, 1H), 3.61 (dd, J = 10.0, 6.0 Hz, 1H), 3.55 (dd, J = 10.0, 8.0 Hz, 1H), 2.88 (d, J = 4.0 Hz, 1H), 2.84 (t, J = 5.0 Hz, 1H), 2.34 (m, J = 9.2, 8.0, 6.0, 6.0 Hz, 1H), 1.67 (d, J = 6.4 Hz, 3H), 1.07 (m, 21H). 13C NMR (CDCl3) δ 129.3, 127.7, 73.7, 65.8, 65.7, 47.6, 18.1, 17.9, 11.8. Anal. Calcd for C16H32O3Si: C, 63.95; H, 10.73. Found: C 63.66; H, 10.96.

2.3.19. Preparation of (±)-(((4S,5S)-2,2-dimethyl-5-(prop-1-ynyl)-1,3-dioxan-4-yl)methoxy)triisopropylsilane (7)

Following general procedure G, 0.083 g of 2a was reacted with 0.004 g of PPTS and 0.13 mL of 2-methoxy propene in 2.8 mL of CH2Cl2 at 0 °C. After work up and solvent evaporation, 0.092 g (97%) of pure six-membered acetonide 7 was obtained as a viscous oil. 1H NMR (CDCl3): δ 4.06 (dd, J = 11.4, 2.8 Hz, 1H), 3.95 (ddd, J = 3.5, 2.8, 1.0 Hz, 1H), 3.92 (dd, J = 11.4, 1.0 Hz, 1H), 3.89 (dd, J = 9.0, 8.8 Hz, 1H), 3.72 (dd, J = 9.0, 4.7 Hz, 1H), 2.59 (m, J = 8.8, 4.7, 3.5 Hz, 1H), 1.82 (d, J = 2.1 Hz, 3H), 1.45 (s, 3H), 1.43 (s, 3H), 1.10 (m, 21H). 13C NMR (CDCl3) δ 98.8, 78.1, 76.5, 71.0, 64.5, 64.3, 29.8, 29.4, 19.0, 17.9, 11.9, 3.77.

2.3.20. Preparation of (±)-((R)-2-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)pent-3-ynyloxy)triisopropylsilane (8)

Following general procedure G, 0.02 g of 6 was reacted with 0.001 g of PPTS and 0.04 mL of 2-methoxy propene in 1.0 mL of CH2Cl2 at 0 °C. After work up, solvent evaporation, and purification by flash chromatography (40:1 Hex/EtOAc), 0.02 g (76%) of pure five-membered acetonide 8 was obtained as a viscous oil. 1H NMR (CDCl3): δ 4.28 (ddd, J = 8.0, 6.0, 4.8 Hz, 1H), 4.05 (dd, J = 8.0, 6.0 Hz, 1H,), 3.85 (dd, J = 8.0, 8.0 Hz, 1H), 3.83 (dd, J = 10.0, 5.1 Hz, 1H), 3.78 (dd, J = 10.0, 9.0 Hz, 1H), 2.63 (ddd, J = 9.0, 5.1, 4.8 Hz, 1H), 1.80 (d, J = 2.3 Hz, 3H), 1.43 (s, 3H), 1.37 (s, 3H), 1.10 (m, 21H). 13C NMR (125 MHz, CDCl3) δ 108.8, 79.1, 70.0, 74.8, 67.9, 64.0, 38.3, 26.5, 25.9, 17.9, 11.9, 3.66.

2.3.21. Preparation of (±)-(((4R,5R)-2,2-dimethyl-5-((Z)-prop-1-enyl)-1,3-dioxan-4-yl)methoxy)triisopropylsilane (9)

Following general procedure G, 0.091 g of 3a was reacted with 0.005 g of PPTS and 0.11 mL of 2-methoxy propene in 3.0 mL of CH2Cl2 at 0 °C. After work up, solvent evaporation, and purification by flash chromatography (50:1 hexane/ethyl acetate), 0.073 g (71%) of pure six-membered acetonide 9 was obtained as a viscous oil. 1H NMR (CDCl3) δ 5.86 (dd, J = 10.6, 10.6 Hz, 1H), 5.65 (dq, J = 10.6, 6.8 Hz, 1H), 4.18 (dd, J = 11.3, 2.2 Hz, 1H), 4.09 (dd, J = 3.8, 2.2, 1.0 Hz, 1H), 3.65 (dd, J = 11.3, 1.0 Hz, 1H), 3.58 (m, J = 9.7, 5.6 Hz, 1H), 3.55 (m, J = 9.7, 7.5 Hz, 1H), 2.54 (m, J = 10.6, 7.5, 5.6, 3.0, Hz, 1H), 1.61 (d, J = 6.6 Hz, 3H), 1.49 (s, 3H), 1.38 (s, 3H), 1.04 (m, 21H). 13C NMR (CDCl3) δ 126.8, 125.8, 98.7, 72.4, 65.9, 64.4, 33.4, 29.6, 19.0, 17.9, 13.2, 11.9.

2.3.22. Preparation of (±)-(2Z,4S,5R)-4-(triethylsilyloxymethyl)-5-(triethylsilyloxy)-6-(triisopropylsilyloxy)-2-hexene (10)

The alkene diol 3a (0.34 g, 1.13 mmol) was submitted to general procedure H using 0.38 mL (2.71 mmol) of TEA and 0.77 mL (3.39 mmol) of TES-OTf in 3.0 mL of DMF. The reaction was stopped after judged completed by TLC. After work-up and solvent evaporation at reduced pressure, 0.73 g (>100%) of a clean crude compound 10 was obtained as a viscous oil and used for the next step without further purification. 1H NMR (CDCl3): δ 5.63 (dq, J = 11.1, 6.7 Hz, 1H), 5.39 (dd, J = 11.1, 9.5 Hz, 1H), 4.07 (ddd, J = 9.0, 5.3, 2.0 Hz, 1H), 3.63 (dd, J = 10.2, 9.2 Hz, 1H), 3.53 (dd, J = 9.5, 5.3 Hz, 1H), 3.48 (dd, J = 9.5, 9.0 Hz, 1H), 3.47 (dd, J = 10.2, 7.0 Hz, 2H), 2.91 (dddd, J = 9.5, 9.2, 7.0, 2.0 Hz, 1H), 1.66 (dd, J = 6.7, 1.6 Hz, 3H), 1.07 (m, 21H), 0.96 (m, 18H), 0.66–0.49 (m, 12H). 13C NMR (CDCl3): δ 127.0, 126.6, 71.2, 65.5, 62.7, 42.1, 18.0, 13.4, 11.9, 6.8 and 6.4, 5.1 and 4.6.

2.3.23. Preparation of (±)-(2S,3R)-2-((Z)-prop-1-enyl)-3-(triethylsilyloxy)-4-(triisopropylsilyloxy)-1-butanol (11)

Following general procedure I, 0.22 g (0.414 mmol) of the bis-TES ether 10 dissolved in 2.1 mL of THF, 0.41 mL of HOAc, and 0.21 mL of water were added. The reaction was refluxed for approximately 3 h. Work up and solvent evaporation yielded 0.19 (>100%) of crude material. The crude was purified by column chromatography (4:1 hexane/ethylacetate) to yield 0.09 g (54%) of pure secondary TES ether 11 as a viscous oil after three consecutive steps. 1H NMR (CDCl3): δ 5.72 (dq, J = 11.0, 6.8 Hz, 1H), 5.41 (dd, J = 11.0, 9.6 Hz, 1H), 3.836 (ddd, J = 7.7, 4.9, 3.0 Hz, 1H), 3.69 (dd, J = 10.9, 6.5 Hz, 1H), 3.62 (dd, J = 10.9, 7.6 Hz, 1H), 3.62 (dd, J = 9.8, 4.9 Hz, 1H), 3.56 (dd, J = 9.8, 7.7 Hz), 2.97 (dddd, J = 9.6, 7.6, 6.5, 3.0 Hz, 1H), 2.18 (bs, Hz, 1H), 1.67 (dd, J = 6.8, 1.7 Hz, 3H), 1.06 (m, 21H), 0.94 (m, 9H), 0.63–0.49 (m, 6H). 13C NMR (CDCl3): δ 128.2, 126.6, 73.9, 65.4, 64.3, 42.6, 18.0, 13.5, 11.9, 6.9, 5.0. Anal. Calcd. for C22H48O3Si2: C, 63.40; H, 11.61. Found: C 63.77; H, 11.64.

2.3.24. Preparation of (±)-(2R,3R)-2-((2S,3R)-3-methyloxiran-2-yl)-3-(triethylsilyloxy)-4-(triisopropylsilyloxy)butan-1-ol (12)

Following general procedure C, VO(acac)2 (0.01 g, 0.042 mmol, 0.014 equiv), toluene (36.0 mL, 0.083 M), 1.20 g of alkenol 11 (2.98 mmol), and 0.85 mL of TBHP (3.278 mmol, 1.1 equiv, 3.85 in toluene) were used. The reaction was completed in 13 min. After work up and solvent evaporation, 1.26 g (98%) of crude was obtained with epoxide 12 as a viscous oil. 1H NMR (CDCl3): δ 3.97 (dd, J = 10.4, 6.2 Hz, 1H), 3.90 (ddd, J = 7.9, 4.6, 4.3 Hz, 1H), 3.81 (dd, J = 10.4, 6.2 Hz, 1H), 3.69 (dd, J = 10.0, 4.6 Hz), 3.63 (dd, J = 10.0, 7.9 Hz), 3.14 (dd, J = 9.2, 3.9 Hz, 1H), 3.08 (dq, J = 5.3, 3.9 Hz, 1H), 2.75 (bs, 1H), 1.85 (dddd, J = 9.2, 6.2, 5.8, 4.3 Hz, 1H), 1.31 (d, J = 5.3 Hz, 3H), 1.05 (m, 21H) 0.94 (t, J = 7.9 Hz, 9H), 0.59 (q, J = 7.9 Hz, 6H). 13C NMR (CDCl3) δ 72.9, 65.7, 63.4, 56.6, 53.0, 41.9, 18.0, 14.0, 11.9, 6.8, 5.7.

2.3.25. Preparation of (±)-(5S,6R)-5-(hydroxymethyl)-6-(triethylsilyloxy)-3-methyl-7-(triisopropylsilyloxy)-1-(trimethylsilyl)hept-1-yn-3-ol (13)

Following general procedure D, 13.0 mL of dry toluene (0.35 M), 1.7 mL (4.1 mmol, 6.0 equiv) of n-BuLi (2.53 M in hexane), 0.6 mL (4.1 mmol) of trimethylsilyl acetylene, and 2.5 mL (4.1 mmol, 6.0 equiv) of Et2AlCl (1.8 M in toluene) were added to a round bottom flask. Followed by the addition of a previously prepared solution of 0.30 g (0.69 mmol) of the epoxy alcohol 12 in 4.6 mL of toluene (0.15 M) and 0.3 mL (0.76 mmol, 1.1 equiv) of n-BuLi (2.53 M in hexanes). After work up, solvent evaporation, and purification by flash chromatography (9:1 hexane/ethylacetate), 0.07 g (20%) of the less polar product 13, 0.03 (7%) of mixture, and 0.09 g (23%) of the most polar product 13 were obtained as a viscous oil.
Spectral data for the least polar product 13: 1H NMR (300 MHz, CDCl3) δ 3.95 (m, 1H), 3.79–3.60 (m, 4H), 2.30 (m,1H), 1.90 (dd, J = 15.1, 4.0 Hz, 1H), 1.63 (dd, J = 15.1, 5.0 Hz, 1H), 1.50 (s, 3H), 1.07 (m, 21H), 0.95 (t, J = 8.0 Hz, 9H), 0.60 (q, J = 8.0 Hz, 6H), 0.14 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 110.5, 86.8, 73.5, 68.0, 65.6, 64.4, 39.9, 39.3, 30.2, 17.9, 11.9, 6.8, 4.9, −0.1. Anal. Calcd for C27H58O4Si3: C, 61.07; H, 11.01. Found: C 61.26; H, 11.02.
Spectral data for the most polar product 13: 1H NMR (500 MHz, CDCl3) δ 4.00 (dd, J = 11.1, 5.0 Hz, 1H), 3.90 (dd, J = 11.2, 5.5 Hz, 1H), 3.86 (m, J = 3.9 Hz, 1H), 3.69 (dd, J = 9.5, 7.2 Hz, 2H), 2.31 (m, 1H), 1.85 (m, 2H), 1.53 (s, 3H), 1.11 (m, 21H), 0.99 (t, J = 7.9 Hz, 9H), 0.65 (q, J = 7.9 Hz, 6H), 0.17 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 109.9, 87.2, 75.5, 66.9, 65., 63.4, 42.1, 41.0, 31.7, 18.0, 11.9, 6.8, 4.9, −0.1.

2.3.26. Preparation of (±)-(2E,4R,5S)-4-(triethylsilyloxymethyl)-5-(triethylsilyloxy)-6-(triisopropylsilyloxy)-2-hexene (14)

The alkene diol 3c (3.7 g, 12.2 mmol) was submitted to general procedure H using 5.1 mL (36.7 mmol) of TEA and 8.3 mL (36.7 mmol) of TES-OTf in 35.0 mL of DMF. The reaction was stopped after stirring for 30 min by adding 30.0 mL of water and 30.0 mL of hexane. After work up and solvent evaporation at reduced pressure, 7.1 g (>100%) of a clean crude 14 was obtained as a viscous oil and used for the next step without further purification. 1H NMR (CDCl3): δ 5.52 (dq, J = 15.4, 6.3 Hz, 1H), 5.34 (dd, J = 15.4, 9.1 Hz, 1H), 3.95 (ddd, J = 7.7, 5.0, 2.0 Hz, 1H), 3.64 (dd, J = 12.0, 10.0 Hz, 1H), 3.54 (dd, J = 12.1, 2.0 Hz, 1H), 3.52 (dd, J = 12.0, 2.0 Hz, 1H), 3.50 (dd, J = 12.1, 5.0 Hz), 2.47 (dddd, J = 10.0, 9.1, 7.7, 2.0 Hz, 1H), 1.67 (dd, J = 6.3, 1.4 Hz, 3H), 1.05 (m, 21H), 0.98–0.91 (m, 18H), 0.64–0.61 (m, 12H). 13C NMR (CDCl3): δ 128.5, 127.6, 71.6, 65.4, 63.6, 48.1, 18.2, 17.9, 11.8, 6.9, 6.7, 5.0, 4.8.

2.3.27. Preparation of (2S,3R)-2-((E)-prop-1-enyl)-3-(triethylsilyloxy)-4-(triisopropylsilyloxy)-1-butanol (15)

Following general procedure G, 6.35 g (11.96 mmol) of the bis-TES ether 14 dissolved in 61.2 mL of THF, 12.2 mL of HOAc, and 6.1 mL of water were added. The reaction was refluxed for approximately 8 h. Work up and solvent evaporation yielded 5.43 g (>100%) of crude material, which was purified by column chromatography (9:1 hexane/ethylacetate) to yield 2.18 g (44%) of pure secondary TES ether 15 as a viscous oil after four consecutive steps. 1H NMR (CDCl3): δ 5.60 (dq, J = 15.0, 6.2 Hz, 1H), 5.45 (dd, J = 15.0, 9.0 Hz, 1H), 3.82 (m, 1H), 3.71–3.61 (m, 4H), 2.54 (m, J = 9.0 Hz, 1H), 1.71 (d, J = 6.2 Hz, 3H), 1.07 (m, 21H), 0.97 (t, J = 7.8 Hz, 9H), 0.62 (q, J = 7.8 Hz, 6H). 13C NMR (CDCl3): δ 129.5, 127.7, 74.3, 65.3, 64.2, 48.7, 18.4, 17.9, 11.8, 6.8, 5.0. Anal. Calcd. for C22H48O3Si2: C, 63.40; H, 11.61. Found: C 63.49; H, 11.57.

2.3.28. Preparation of (±)-(2S,3S)-2-((2S,3S)-3-methyloxiran-2-yl)-3-(triethylsilyloxy)-4-(triisopropylsilyloxy)butan-1-ol (16) and the Minor Isomer

Following general procedure C, VO(acac)2 (0.019 g, 0.073 mmol), toluene (63.0 mL, 0.083 M), 2.18 g of alkenol 15 (5.23 mmol), and 1.5 mL of TBHP (5.75 mmol, 1.1 equiv, 3.85 in toluene) were combined. The reaction was completed in 13 min. After work up, solvent evaporation, and purification by Flash column chromatography (9:1) hexane/ethyl acetate yielded 1.16 g (51%) of a 85:15 mixture of epoxy alcohols 16a and its minor isomer 16b as a viscous oil. 1H NMR (CDCl3): δ 3.94 (m, J = 11.0, 3.5 Hz, 1H), 3.94 (m, J = 8.5, 5.9, 5.0 Hz, 1H), 3.79 (dd, J = 11.0, 6.3 Hz, 1H), 3.71 (dd, J = 10.0, 5.0 Hz), 3.61 (dd, J = 10.0, 8.5 Hz), 2.90 (dq, J = 5.2, 2.3 Hz, 1H), 2.85 (dd, J = 8.5, 2.3 Hz, 1H), 2.55 (bs, 1H), 1.67 (dddd, J = 8.5, 6.3, 5.9, 3.5 Hz, 1H), 1.30 (d, J = 5.1 Hz, 3H), 1.05 (m, 21H) 0.94 (t, J = 7.9 Hz, 9H), 0.59 (q, J = 7.8 Hz, 6H). 13C NMR (CDCl3) δ 72.7, 65.3, 63.1, 58.4, 54.4, 46.4, 17.9, 17.5, 11.8, 6.8, 4.9. Anal. Calcd. for C22H48O4Si2: C, 61.05; H, 11.18. Found: C 61.36; H, 11.25.
Spectral data for the minor isomer 16b: (±)-(2S,3S)-2-((2R,3R)-3-methyloxiran-2-yl)-3-(triethylsilyloxy)-4-(triisopropylsilyloxy)butan-1-ol: 1H NMR (CDCl3) 4.03–3.98 (m, 2H), 3.79 (d, J = 6.1 Hz, 1H), 3.76 (m, 1H), 3.57 (dd, J = 9.9, 6.9 Hz), 2.97–2.85 (m, 2H), 2.85 (dd, J = 8.5, 2.3 Hz, 1H), 1.85 (m, 1H), 1.32 (d, J = 2.0 Hz, 3H), 1.05 (m, 21H), 0.94 (t, J = 7.9 Hz, 9H), 0.59 (q, J = 7.8 Hz, 6H), 13C NMR (CDCl3) δ 73.4, 65.7, 61.4, 58.1, 53.3, 46.6, 17.9, 17.7, 11.8, 6.8, 4.9. Anal. Calcd. for C22H48O4Si2: C, 61.05; H, 11.18. Found: C 61.28; H, 11.41.

3. Results and Discussion

The optically active 2,3-epoxy alcohols 1-cis and 1-trans were prepared via Sharpless asymmetric epoxidation (SAE) of the respective allylic alcohols 5-Z and 5-E (Table 1) [46,47]. We decided to synthesize optically active epoxy alkanols to expand the scope of our second-generation approach and demonstrate the viability of the employment of enantioenriched starting materials. The SAE of allylic alcohol 5-Z required a couple of days to completed, while the reaction with the trans-allylic alcohol 5-E was faster, generally completed in 2 h. The enantiomeric excess (ee) of both enantiomers of 1-cis epoxide was 80%, and for both enantiomers of the 1-trans epoxide was 94%, which were measured using the Alexakis method [44]. The 31P NMR spectra of the Alexakis ester of (-)-1-cis and (+)-1-cis are shown in Supporting information.
As previously anticipated, the epoxide-opening reactions in our methodology did not depend on whether racemic or optically active 2,3-epoxy diols were used. Therefore, the studies involving Grignard reagents were conducted using racemic epoxides, which were prepared from the allylic alcohols 5- and 5-E. These precursors were epoxidized with m-CPBA, affording the corresponding epoxides 1-cis and 1-trans, respectively, in good yields, as shown in Scheme 4.
The copper-catalyzed Grignard epoxide cleavage reaction was investigated using second-generation TIPS-protected cis- and trans-epoxy alcohols (1-cis and 1-trans) with various alkenyl Grignard reagents (Scheme 3, Table 2). The selection of alkenyl Grignard reagents was based on their commercial availability and potential utility in the synthesis of polypropionate fragments within our epoxide cleavage methodology.
Cleavage of epoxides 1-cis and 1-trans with cis-1-propenylmagnesium bromide (entries 1 and 2) proceeded with excellent regioselectivity (95:5), affording the corresponding cis-homoallylic diols: anti-1,3-diol (3a) in 66% yield and syn-1,3-diol (3b) in 88% yield (Table 1: entries 1 and 2). The reaction with trans-1-propenylmagnesium bromide (Table 1: entries 3 and 4) also exhibited excellent regioselectivity (>95:5). Surprisingly, this was accompanied by the formation of a mixture of trans/cis alkenols, resulting in a moderate ~65:35 trans/cis diastereoselectivity and yielding anti,trans-1,3-diol (3c) and syn,trans-1,3-diol (3d) as major products. This concomitant partial double-bond isomerization of trans-1-propenylmagnesium bromide to its cis isomer had been previously reported by our group [38]. Although this isomerization can be minimized by carefully controlling the reagent formation conditions, the reaction is impractical for synthetic purposes due to the inseparability of the resulting isomeric mixture by chromatography.
Cleavage of epoxides 1-cis and 1-trans with vinylmagnesium bromide (entries 5 and 6) proceeded with excellent regioselectivity (>95:5), affording the terminal anti-homoallylic 1,3-diol 3e at 81% yield and the terminal syn-homoallylic 1,3-diol 3f at 51% yield (Table 1: entries 5 and 6). The use of α-(trimethylsilyl)vinylmagnesium bromide (Table 1: entries 7 and 8) also afforded excellent regioselectivity (>95:5), with moderate (46–54%) to good (81%) yields of the corresponding syn/anti-homoallylic 1,3-diols 3g and 3h, respectively (Table 1: entries 7 and 8).
These results highlight the excellent regioselectivity achieved using alkenyl Grignard reagents for the cleavage of TIPS-monoprotected epoxides 1-cis and 1-trans, which surpassed that reported with the Bn-monoprotected cis- and trans-2,3-epoxy alcohols [36,43]. The improved selectivity observed with the second-generation epoxides can be attributed to the bulky TIPS ether, which effectively suppresses nucleophilic attack at the more hindered C3 position. Furthermore, coordination of the Grignard reagent with the hydroxyl group (in its alkoxide form) likely facilitates exclusive attack at the less hindered C2 position to form 1,3-diols in a regioselective and stereoselective manner. These results highlight the role of the free primary alcohol in directing nucleophilic attack at C2.
Although the epoxide cleavage methodology using alkenyl Grignard reagents provides one-step access to syn- and anti-hydroxymethyl 1,3-diols (3a–h) with excellent regioselectivity, the diastereoselective synthesis of trans-homoallylic 1,3-diols (3c and 3d) by this approach remains a challenge. Fortunately, we previously reported an alternative two-step synthesis of trans-homoallylic alcohols 3b and 3c (Scheme 1 and Scheme 4) [34,35]. In this strategy, TIPS-protected epoxy alcohol 1-cis was regioselectively cleaved (90:10) using the diethylpropynyl alanate reagent, affording the corresponding homopropargylic alcohol 2a (Scheme 5). Subsequent sodium/ammonia reduction of the homopropargylic 1,3-diol 2a exclusively produced the trans-homoallylic 1,3-diol 3c in 62% isolated yield for two consecutive steps. Similarly, propynyl alanate cleavage of 1-trans, followed by trans-selective reduction, afforded only the syn-homoallylic 1,3-diol 3d in 53% isolated yield for two consecutive steps. This propynyl alanate–reduction route (Scheme 1 and Scheme 5) complements the alkenyl Grignard methodology (Scheme 3), and together they represent a second-generation strategy that provides access to syn- and anti-hydroxymethyl 1,3-diols (3a–h) with excellent region- and diastereoselectivities.
The stereoselectivity of the propenyl cis/trans geometry in the homoallylic 1,3-diol products (3a-3d) was determined by 1H and 13C NMR spectroscopy. The stereochemistry of the resulting alkenes was established by analyzing the coupling constants of the vinyl protons, with trans isomers displaying larger Jab values (13–15 Hz) compared to cis isomers (10–11 Hz). The 13C NMR spectra showed diagnostic allylic methyl signals at 13.4–13.5 ppm for cis alkenes, and at 18.1–18.2 ppm for the trans isomers. The regioselectivity of the epoxide ring opening of 2,3-epoxy diols 1-cis and 1-trans was determined by 1H and 13C NMR spectroscopy. All 1,3-diols 3a–h exhibited a single diagnostic peak corresponding to the methine C2 carbon atom, and no signals consistent with the C3 methine carbon of the 1,2-diols were observed.
To further validate the regioselectivity of the epoxide cleavage reactions with Grignard and propynyl alanes, acetonides 7, 8, and 9 were formed from the resulting 1,3- and 1,2-diols (Scheme 6). Representative examples are summarized in Table 3. The formation of six-membered acetonides was observed when nucleophilic attack occurred at the C2 position (Table 2: entries 1 and 3), as expected from reactions involving organoaluminum ate complexes and Grignard reagents. In contrast, formation of a five-membered acetonide confirmed nucleophilic attack at the C3 position (Table 2: entry 2). In general, the 13C NMR spectra showed signals at approximately 29 and 19 ppm for the gem-dimethyl carbons of the six-membered acetonides, whereas the five-membered acetonide displayed two signals in the range of 25.9–26.6 ppm.
The conformational models presented in Scheme 7 explain the expected 13C NMR chemical shifts for the acetonide gem-dimethyls. The structural differences between the six- (chair) and five-membered acetonide (enveloped) result in significantly different 13C NMR spectra of the ketal carbon and associated methyl substituents. The six-membered acetonides adopt two chair conformations which interconvert. The equilibrium between these forms depends on the substituents propensity to occupy the given pseudo axial or pseudo equatorial positions. Therefore, the 1,3-diaxial interactions present in the chair–chair interconversions will provide a more stable and “frozen” chair, thus, the axial and equatorial methyl carbons are not chemically equivalents. The five-membered acetonides are in “conformational flux”, where the methyl group’s chemical shifts are almost equivalents with the rapid interchange.
Table 2 also includes the 13C chemical shifts of the ketal carbons, which are consistent with the findings reported [48,49]. Specifically, the six-membered acetonides 7 and 9 exhibited resonances above 98.8–98.9 ppm (Table 3: entries 1 and 3), while the five-membered acetonide 8 appeared around 108.8 ppm (Table 3: entry 2). These diagnostic signals were key in identifying the nature of the acetonides. In addition, the methine protons Ha and Hb in an anti-relationship within six-membered acetonides 7 and 9 displayed coupling constants Jab = 3.0–4.0 Hz, consistent with an axial–equatorial arrangement (see Scheme 6 and Scheme 7). In contrast, the six-membered acetonide derived from syn-diol 2b confirmed the syn relationship, as evidenced by the larger coupling constants Jab = 8–10 Hz.
We explored the potential application of this second-generation methodology for the synthesis of polypropionate fragments containing hydroxymethyl 1,3-diol motifs. For this purpose, anti-homoallylic 1,3-diol 3a was used (Scheme 8). Application of the TES diprotection followed by selective TES deprotection afforded homoallylic alcohol 11 with the free primary alcohol. Subsequent microwave-assisted epoxidation using VO(acac)2/TBHP stereoselectively provided the anti,cis-3,4-epoxy alcohol 12 in >95:5 diastereoselectivity in 13 min with 98% yield (Scheme 8) [35]. Alternatively, epoxidation of 11 at room temperature for 24 h afforded the desired epoxide 12 in good yield (85%). Next, epoxide 12 was subjected to cleavage with a TMS-alkynyl aluminum reagent. However, the major products were tertiary alcohols 13a and 13b, formed as a diastereoselective 65:35 mixture due to alkynyl addition to a rearranged γ-hydroxy ketone intermediate. These unexpected products arose from the Lewis acidic nature of the aluminum reagent, which promotes epoxide-to-ketone rearrangement in susceptible substrates [50,51]. When the reaction was performed without pretreatment of epoxide 12 with n-BuLi, the diastereoselectivity was inverted to 43:57, thus providing a potential complementary method for the preparation of fragments 13a and 13b. Additionally, product 13a was identified as an alternative precursor for the C5–C10 fragment found in the tylosin family because this compound contains the correct stereochemistry and a hydroxymethyl group at C6, which can be further oxidized to form the required aldehyde in the natural compound [3]. Fragment 13a also possesses a tertiary alcohol at C8 adjacent to the deoxygenated C7 carbon. Although this approach does not afford the tertiary alcohol with stereocontrol, isolation of both diastereomers was straightforward, offering a valuable opportunity to assign the relative stereochemistry of each diastereomer—information that has not yet been determined. If the primary hydroxy group is no longer required after serving its role in the synthesis—as is the case for the C5–C10 fragment of mycinamicin I and the polypropionate chain of aldgamacins N/O/J—it can be removed at any stage via tosylation, followed by hydride reduction to yield the C6 methyl group [52].
Recognizing the synthetic opportunities this finding offers for polypropionate synthesis, the anti-hydroxymethyl 1,3-diol 3b motif can serve as a key structural element in target molecules (Scheme 9). For instance, this trans-homoallylic diol appears in the C14–C15 fragment of tylosin, mycinamicins, aldgamacins, tianchimycin, swalpamycin, and the chalcomycin series, all of which also require a C20-primary alcohol. Furthermore, trans-homoallylic alcohol 3b could serve as a precursor to the C11–C14 fragment found in mycinamicins III and IV, since it contains both the anti-1,3-diol stereochemistry and the required trans-alkene [9]. We therefore converted anti-1,3-diol 3b into the corresponding homoallylic alcohol 15, which was subsequently transformed stereoselectively into the anti-syn-trans epoxide 16 with an 85:15 diastereoselectivity using a microwave heating protocol (Scheme 9) [35]. The epoxidation of alkenol 15 was also carried out at room temperature; although a similar yield and diastereoselectivity were obtained, the reaction required 24 h to reach completion. Epoxide 16 mimics the C11–C14 fragment present in mycinamicin I and the aldgamacins—both of which require an anti-hydroxymethyl 1,3-diol trans-epoxide for their construction [9].

4. Summary and Conclusions

In summary, we reported a complementary second-generation methodology for the enantio-, regio- and diastereoselective synthesis of syn- and anti-hydroxymethyl 1,3-diols via copper-catalyzed epoxide cleavage using alkenyl Grignard reagents. The use of cis-propenylmagnesium bromide enabled direct access to cis-homoallylic alcohols with excellent regioselectivity and yield, eliminating the need for a partial hydrogenation step and streamlining the synthetic sequence to two steps. In contrast, the trans-propenylmagnesium bromide reagent resulted in undesired Z/E isomerization, limiting its utility. Complementary use of propynyl alanate addition followed by sodium/ammonia reduction provided a practical route to access trans-homoallylic diols with high selectivity. The success of vinyl Grignard additions also opens new avenues for the synthesis of polypropionate fragments bearing terminal homoallylic 1,3-diols. The - and diastereoselectivity of the epoxide opening reactions were confirmed by detailed spectroscopic analysis of the products, including 1H and 13C NMR, which showed characteristic coupling constants and chemical shift patterns consistent with the assigned stereochemistry. These one-step alkenyl Grignard and two-step alkynyl alane-reduction strategies expand the synthetic toolbox for the efficient construction of polyketide-derived structures—such as those found in tylosin, mycinamicins, and aldgamacins—that require the incorporation of syn- and anti-hydroxymethyl 1,3-diols.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/org6030029/s1, Figure S1. 1H NMR Spectrum of Compound 1-cis (500 MHz, CDCl3), Figure S2. 13C NMR Spectrum of Compound 1-cis (125 MHz, CDCl3), Figure S3. 1H NMR Spectrum of Compound 1-trans (500 MHz, CDCl3), Figure S4. 13C DEPT-135 NMR Spectrum of Compound 4-trans (125 MHz, CDCl3), Scheme S1. Preparation of the Alexakis phosporamidates derived from 1-cis for the determination of the ee by 31P NMR, Figure S5. 31P NMR spectra of Alexakis esters of 1-cis derived from (+)-1-cis-CDA, Scheme S2. Preparation of the Alexakis phosporamidates derived from 1-trans for the determination of the ee by 31P NMR, Figure S6. 31P NMR spectra of Alexakis esters of 1-trans derived from (±)-1-trans-CDA, Figure S7. 1H NMR Spectrum of Compound 3a (500 MHz, CDCl3), Figure S8. 13C NMR Spectrum of Compound 3a (125 MHz, CDCl3), Figure S9. 1H NMR Spectrum of Compound 3b (500 MHz, CDCl3), Figure S10. 13C NMR Spectrum of Compound 3b (500 MHz, CDCl3), Figure S11. 1H NMR Spectrum of Compound 3c (500 MHz, CDCl3), Figure S12. 13C NMR Spectrum of Compound 3c (125 MHz, CDCl3), Figure S13. 1H NMR Spectrum of Compound 3d (500 MHz, CDCl3), Figure S14. 13C DEPT-135 NMR Spectrum of Compound 3d (125 MHz, CDCl3), Figure S15. 1H NMR Spectrum of Compound 3e (125 MHz, CDCl3), Figure S16. 13C DEPT-135 NMR Spectrum of Compound 3e (500 MHz, CDCl3), Figure S17. 13C NMR Spectrum of Compound 3f (500 MHz, CDCl3), Figure S18. 1H NMR Spectrum of Compound 3g (125 MHz, CDCl3), Figure S19. 13C APT NMR Spectrum of Compound 3g (500 MHz, CDCl3), Figure S20. 1H NMR Spectrum of Compound 3h (125 MHz, CDCl3), Figure S21. 13C APT NMR Spectrum of Compound 3h (500 MHz, CDCl3), Figure S22. 1H NMR Spectrum of 2a (500 MHz, CDCl3), Figure S23. 13C NMR Spectrum of 2a (125 MHz, CDCl3), Figure S24. 1H NMR Spectrum of 6 (500 MHz, CDCl3), Figure S25. 13C NMR Spectrum of 6 (125 MHz, CDCl3), Figure S26. 1H NMR Spectrum of 2b (125 MHz, CDCl3), Figure S27. 13C NMR Spectrum of 2b (125 MHz, CDCl3), Figure S28. 1H NMR Spectrum of Compound 7 (500 MHz, CDCl3), Figure S29. 13C NMR Spectrum of Compound 7 (125 MHz, CDCl3), Figure S30. 1H NMR Spectrum of Compound 8 (500 MHz, CDCl3), Figure S31. 13C NMR Spectrum of Compound 8 (125 MHz, CDCl3), Figure S32. 1H NMR Spectrum of Compound 9 (500 MHz, CDCl3), Figure S33. 13C NMR Spectrum of Compound 9 (125 MHz, CDCl3), Figure S34. 1H NMR Spectrum of Compound 10 (300 MHz, CDCl3), Figure S35. 13C NMR Spectrum of Compound 10 (75 MHz, CDCl3), Figure S36. 1H NMR Spectrum of Compound 11 (300 MHz, CDCl3), Figure S37. 13C NMR Spectrum of Compound 11 (75 MHz, CDCl3), Figure S38. 1H NMR Spectrum of Compound 12 (300 MHz, CDCl3), Figure S39. 13C NMR Spectrum of Compound 12 (75 MHz, CDCl3), Figure S40. 1H NMR Spectrum of Compound 13a (300 MHz, CDCl3), Figure S41. 13C NMR Spectrum of Compound 13a (75 MHz, CDCl3), Figure S42. 1H NMR Spectrum of Compound 13b (300 MHz, CDCl3), Figure S43. 13C NMR Spectrum of Compound 13b (75 MHz, CDCl3), Figure S44. 1H NMR Spectrum of Compound 14 (300 MHz, CDCl3), Figure S45. 13C NMR Spectrum of Compound 14 (75 MHz, CDCl3), Figure S46. 1H NMR Spectrum of Compound 15 (300 MHz, CDCl3), Figure S47. 13C NMR Spectrum of Compound 15 (75 MHz, CDCl3), Figure S48. 1H NMR Spectrum of Compound 16 (300 MHz, CDCl3), Figure S49. 13C NMR Spectrum of Compound 16 (75 MHz, CDCl3).

Author Contributions

Conceptualization, R.R.R.-B. and J.A.P.; methodology, R.R.R.-B. and J.A.P.; formal analysis, R.R.R.-B. and J.A.P.; investigation, R.R.R.-B. and J.A.P.; resources, R.R.R.-B. and J.A.P.; writing—original draft preparation, R.R.R.-B.; writing—review and editing R.R.R.-B.; funding acquisition, R.R.R.-B. and J.A.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by NIH-RISE, grant number 5R25-GM-061151-11 and NIH SCORE, grant number 5SC1-GM-084826-04. We also thank the R.R.R.-B. Fellowships, the Alfred P. Sloan Foundation, and Puerto Rico Industrial Development Company (PRIDCO) for their support.

Data Availability Statement

The data supporting the findings of this study are provided in the article and Supplementary Materials. Additional inquiries should be directed to the corresponding author.

Acknowledgments

The authors would like to express their sincere gratitude to the Department of Chemistry at the University of Puerto Rico, Río Piedras Campus, for their continued support throughout this project. We are especially thankful to the Materials Characterization Center (MCC) for access to the NMR facilities. This manuscript is dedicated to José A. Prieto in recognition of his prolific career as a professor and researcher, and in celebration of his recent distinction as Emeritus. During the preparation of this manuscript, the authors used ChatGPT (OpenAI, GPT-4, May 2024 version) for the sole purpose of grammar revision and editorial refinement. All scientific content, interpretations, and conclusions are the authors’ own. This article is a revised and expanded version of a paper entitled Synthesis of anti- and syn-hydroxymethyl 1,3-diol motifs based on the regioselective cleavage of 2,3-epoxy alcohols using Grignard and organoaluminum reagents: application to the polypropionate synthesis, which was presented at ACS Spring: Philadelphia, USA, 20 April 2020 [53].

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Dewick, P.M. Medicinal Natural Products: A Biosynthetic Approach, 3rd ed.; John Wiley & Sons Ltd.: Chichester, UK, 2009. [Google Scholar]
  2. Schönfeld, W.; Kirst, H.A. Macrolide Antibiotics; Springer Science & Business Media: Basel, Switzerland, 2002; ISBN 3-7643-6186-7. [Google Scholar]
  3. Kirst, H.A.; Wild, G.M.; Baltz, R.H.; Hamill, R.L.; Ott, J.L.; Counter, F.T.; Ose, E.E. Structure-Activity Studies among 16-Membered Macrolide Antibiotics Related to Tylosin. J. Antibiot. 1982, 35, 1675–1682. [Google Scholar] [CrossRef] [PubMed]
  4. Kinoshita, K.; Takenaka, S.; Hayashi, M. Isolation of Proposed Intermediates in the Biosynthesis of Mycinamicins. J. Chem. Soc. Chem. Commun. 1988, 943–945. [Google Scholar] [CrossRef]
  5. Kinoshita, K.; Takenaka, S.; Suzuki, H.; Yamamoto, T.; Morohoshi, T.; Hayashi, M. Mycinamicin Biosynthesis: Isolation and Structural Elucidation of Novel Macrolactones and a Seco Acid Produced by a Mutant of Micromonospora Griseorubida. J. Chem. Soc. Chem. Commun. 1992, 957–959. [Google Scholar] [CrossRef]
  6. Kinoshita, K.; Takenaka, S.; Hayashi, M. Mycinamicins, New Macrolide Antibiotics. XII. Isolation and Structural Elucidation of Mycinamicins X and XI. J. Antibiot. 1991, 44, 1270–1273. [Google Scholar] [CrossRef]
  7. Hayashi, M.; Ohno, M.; Katsumata, S.; Satoi, S. Mycinamicins, New Macrolide Antibiotics. IV. Structure of Mycinamicin III. J. Antibiot. 1981, 34, 276–281. [Google Scholar] [CrossRef]
  8. Späth, G.; Fürstner, A. Total Synthesis of Mycinamicin IV as Integral Part of a Collective Approach to Macrolide Antibiotics. Chem. A Eur. J. 2022, 28, e202104400. [Google Scholar] [CrossRef]
  9. Herlé, B.; Späth, G.; Schreyer, L.; Fürstner, A. Total Synthesis of Mycinolide IV and Path-Scouting for Aldgamycin N. Angew. Chem. Int. Ed. 2021, 60, 7893–7899. [Google Scholar] [CrossRef]
  10. Wang, C.-X.; Ding, R.; Jiang, S.-T.; Tang, J.-S.; Hu, D.; Chen, G.-D.; Lin, F.; Hong, K.; Yao, X.-S.; Gao, H. Aldgamycins J–O, 16-Membered Macrolides with a Branched Octose Unit from Streptomycetes Sp. and Their Antibacterial Activities. J. Nat. Prod. 2016, 79, 2446–2454. [Google Scholar] [CrossRef] [PubMed]
  11. Wang, X.; Tabudravu, J.; Jaspars, M.; Deng, H. Tianchimycins A–B, 16-Membered Macrolides from the Rare Actinomycete Saccharothrix Xinjiangensis. Tetrahedron 2013, 69, 6060–6064. [Google Scholar] [CrossRef]
  12. Franco, C.M.M.; Gandhi, J.N.; Chatterjee, S.; Ganguli, B.N. Swalpamycin, a New Macrolide Antibiotic. I. Taxonomy of the Producing Organism, Fermentation, Isolation and Biological Activity. J. Antibiot. 1987, 40, 1361–1367. [Google Scholar] [CrossRef]
  13. Chatterjee, S.; Reddy, G.C.S.; Franco, C.M.M.; Rupp, R.H.; Ganguli, B.N.; Fehlhaber, H.-W.; Kogler, H. Swalpamycin, a New Macrolide Antibiotic. II. Structure Elucidation. J. Antibiot. 1987, 40, 1368–1374. [Google Scholar] [CrossRef] [PubMed]
  14. Asolkar, R.N.; Maskey, R.P.; Helmke, E.; Laatsch, H. Chalcomycin B, a New Macrolide Antibiotic from the Marine Isolate Streptomyces Sp. B7064. J. Antibiot. 2002, 55, 893–898. [Google Scholar] [CrossRef]
  15. Woo, P.W.K.; Dion, H.W.; Bartz, Q.R. The Structure of Chalcomycin. J. Am. Chem. Soc. 1964, 86, 2726–2727. [Google Scholar] [CrossRef]
  16. Schmitz, F.J.; Gunasekera, S.P.; Yalamanchili, G.; Hossain, M.B.; Van Der Helm, D. Tedanolide: A Potent Cytotoxic Macrolide from the Caribbean Sponge Tedania Ignis. J. Am. Chem. Soc. 1984, 106, 7251–7252. [Google Scholar] [CrossRef]
  17. Taylor, R.E.; Hearn, B.R.; Ciavarri, J.P. A Divergent Approach to the Myriaporones and Tedanolide: Completion of the Carbon Skeleton of Myriaporone 1. Org. Lett. 2002, 4, 2953–2955. [Google Scholar] [CrossRef] [PubMed]
  18. Ishibashi, M.; Moore, R.E.; Patterson, G.M.L.; Xu, C.; Clardy, J. Scytophycins, Cytotoxic and Antimycotic Agents from the Cyanophyte Scytonema Pseudohofmanni. J. Org. Chem. 1986, 51, 5300–5306. [Google Scholar] [CrossRef]
  19. Rinehart, K.L.; Tachibana, K. The 1994 Japan-U.S. Seminar on Bioorganic Marine Chemistry, Meeting Report. J. Nat. Prod. 1995, 58, 344–358. [Google Scholar] [CrossRef]
  20. Knöll, W.M.; Rinehart Jr, K.L.; Willey, P.F.; LI, L.H. Streptovaricin U, an Acyclic Ansamycin. J. Antibiot. 1980, 33, 249–251. [Google Scholar] [CrossRef]
  21. Milavetz, B.I.; Carter, W.A. Streptovaricins. Pharmacol. Ther. Part A Chemother. Toxicol. Metab. Inhib. 1977, 1, 289–305. [Google Scholar] [CrossRef]
  22. Wang, B.-L.; Gao, H.-T.; Li, W.-D.Z. Total Synthesis of (+)-Iresin. J. Org. Chem. 2015, 80, 5296–5301. [Google Scholar] [CrossRef]
  23. Trost, B.M.; Nishimura, Y.; Yamamoto, K. A Total Synthesis of Aphidicolin. J. Am. Chem. Soc. 1979, 101, 1328–1330. [Google Scholar] [CrossRef]
  24. Su, B.-N.; Takaishi, Y.; Kusumi, T. Morinols A-L, Twelve Novel Sesquineolignans and Neolignans with a New Carbon Skeleton from Morina Chinensis. Tetrahedron 1999, 55, 14571–14586. [Google Scholar] [CrossRef]
  25. Gordaliza, M.; García, P.A.; Miguel Del Corral, J.M.; Castro, M.A.; Gómez-Zurita, M.A. Podophyllotoxin: Distribution, Sources, Applications and New Cytotoxic Derivatives. Toxicon 2004, 44, 441–459. [Google Scholar] [CrossRef]
  26. Kobayashi, H.; Sunaga, R.; Furihata, K.; Morisaki, N.; Iwasaki, S. Isolation and Structures of an Antifungal Antibiotic, Fusarielin A, and Related Compounds Produced by a Flusarium Sp. J. Antibiot. 1995, 48, 42–52. [Google Scholar] [CrossRef]
  27. Bandini, M.; Cozzi, P.G.; Licciulli, S.; Umani-Ronchi, A. A Cross Metathesis Based Protocol for the Effective Synthesis of Function-alised Allyl Bromides and Chlorides. Synthesis 2004, 3, 409–414. [Google Scholar] [CrossRef]
  28. Zhang, Y.J.; Yang, J.H.; Kim, S.H.; Krische, M.J. Anti-Diastereo- and Enantioselective Carbonyl (Hydroxymethyl)Allylation from the Alcohol or Aldehyde Oxidation Level: Allyl Carbonates as Allylmetal Surrogates. J. Am. Chem. Soc. 2010, 132, 4562–4563. [Google Scholar] [CrossRef]
  29. Sasaki, M.; Tanino, K.; Miyashita, M. Stereospecific Alkyl and Alkynyl Substitution Reactions of Epoxy Sulfides with Organoaluminums with Double Inversion of the Configuration. J. Org. Chem. 2001, 66, 5388–5394. [Google Scholar] [CrossRef] [PubMed]
  30. Roush, W.R.; Adam, M.A.; Peseckis, S.M. Regioselectivity of the Reactions of Trialkylaluminum Reagents with 2,3-Epoxyalcohols: Application to the Synthesis of α-Chiral Aldehydes. Tetrahedron Lett. 1983, 24, 1377–1380. [Google Scholar] [CrossRef]
  31. Ahn, K.H.; Kim, J.S.; Jin, C.S.; Kang, D.H.; Han, D.S.; Shin, Y.S.; Kim, D.H. Regioselective Oxirane Ring Opening of Trans-2,3-Epoxy Alcohols with Arylaluminum Complexes. Synlett 1992, 1992, 306–308. [Google Scholar] [CrossRef]
  32. Chong, J.M.; Cyr, D.R.; Mar, E.K. Regioselective Opening of 2,3-Epoxy Alcohols with Organocuprates. Enhanced C-2 Selectivity through Solvent Effects. Tetrahedron Lett. 1987, 28, 5009–5012. [Google Scholar] [CrossRef]
  33. Yamaguchi, M.; Hirao, I. A Novel Alkynylation Reaction of Epoxy Alcohols: Use in the Synthesis of Erythro-6-Acetoxyhexadecan-5-Olide. J. Chem. Soc. Chem. Commun. 1984, 3, 202. [Google Scholar] [CrossRef]
  34. Prieto, J.A.; Torres, J.R.; Rodríguez-Berrios, R. Regiocontrolled Ring Opening of Monoprotected 2,3-Epoxy-1,4-Diols by Using Alkynyl Aluminum Reagents: Synthesis of Differentially Monoprotected Alkynyl Triol Derivatives. Synlett 2014, 25, 433–437. [Google Scholar] [CrossRef]
  35. Rodríguez-Berríos, R.R.; Torres, G.; Prieto, J.A. Stereoselective VO (Acac) 2 Catalyzed Epoxidation of Acyclic Homoallylic Diols. Complementary Preparation of C2-Syn-3, 4-Epoxy Alcohols. Tetrahedron 2011, 67, 830–836. [Google Scholar] [CrossRef] [PubMed]
  36. Tius, M.A.; Fauq, A.H. Copper(I)-Catalyzed Reactions of .Beta.,.Gamma.-Epoxy Alcohols with Grignard Reagents. J. Org. Chem. 1983, 48, 4131–4132. [Google Scholar] [CrossRef]
  37. Lipshutz, B.H.; Kozlowski, J.; Wilhelm, R.S. Chemistry of Higher Order Mixed Organocuprates. 2. Reactions of Epoxides. J. Am. Chem. Soc. 1982, 104, 2305–2307. [Google Scholar] [CrossRef]
  38. Rodríguez, D.; Mulero, M.; Prieto, J.A. Highly Regioselective Copper-Catalyzed Cis-and Trans-1-Propenyl Grignard Cleavage of Hindered Epoxides. Application in Propionate Synthesis. J. Org. Chem. 2006, 71, 5826–5829. [Google Scholar] [CrossRef]
  39. Rodríguez-Berríos, R.R.; Isbel, S.R.; Bugarin, A. Epoxide-Based Synthetic Approaches toward Polypropionates and Related Bioactive Natural Products. Int. J. Mol. Sci. 2023, 24, 6195. [Google Scholar] [CrossRef]
  40. Tirado, R.; Torres, G.; Torres, W.; Prieto, J.A. Regioselective Cleavage of Cis- and Trans-2-Methyl-3,4-Epoxy Alcohols with Diethylpropynyl Aluminum. Tetrahedron Lett. 2005, 46, 797–801. [Google Scholar] [CrossRef]
  41. Torres, W.; Torres, G.; Prieto, J.A. Synthesis of Stereotetrads by Regioselective Cleavage of Diastereomeric MEM-Protected 2-Methyl-3, 4-Epoxy Alcohols with Diethylpropynyl Aluminum. Synlett 2012, 23, 2534–2538. [Google Scholar]
  42. Cruz-Montañez, A.; Morales-Rivera, K.F.; Torres, W.; Valentín, E.M.; Rentas-Torres, J.; Prieto, J.A. Reiterative Epoxide-Based Strategies for the Synthesis of Stereo-n-Ads and Application to Polypropionate Synthesis. A Personal Account. Inorg. Chim. Acta 2017, 468, 28–37. [Google Scholar] [CrossRef]
  43. Izzo, I.; Scioscia, M.; Del Gaudio, P.; De Riccardis, F. First Enantioselective Non-Biological Synthesis of Asymmetrised Tris(Hydroxymethyl)Methane (THYM*) and Bis(Hydroxymethyl)Acetaldehyde (BHYMA*). Tetrahedron Lett. 2001, 42, 5421–5424. [Google Scholar] [CrossRef]
  44. Alexakis, A.; Frutos, J.C.; Mutti, S.; Mangeney, P. Chiral Diamines for a New Protocol To Determine the Enantiomeric Composition of Alcohols, Thiols, and Amines by 31P, 1H, 13C, and 19F NMR. J. Org. Chem. 1994, 59, 3326–3334. [Google Scholar] [CrossRef]
  45. Rentas-Torres, J.; Prieto, J.A. Studies Toward the Preparation of the Polypropionate Segments of Scytophycin C and Mycalolide A: First and Second Generation Epoxide-Based Approaches. Ph.D. Thesis, University of Puerto Rico, Rio Piedras Campus, San Juan, Puerto Rico, 2013. [Google Scholar]
  46. Gao, Y.; Klunder, J.M.; Hanson, R.M.; Masamune, H.; Ko, S.Y.; Sharpless, K.B. Catalytic Asymmetric Epoxidation and Kinetic Resolution: Modified Procedures Including in Situ Derivatization. J. Am. Chem. Soc. 1987, 109, 5765–5780. [Google Scholar] [CrossRef]
  47. Katsuki, T.; Sharpless, K.B. The First Practical Method for Asymmetric Epoxidation. J. Am. Chem. Soc. 1980, 102, 5974–5976. [Google Scholar] [CrossRef]
  48. Rychnovsky, S.D.; Skalitzky, D.J. Stereochemistry of Alternating Polyol Chains: 13C NMR Analysis of 1,3-Diol Acetonides. Tetrahedron Lett. 1990, 31, 945–948. [Google Scholar] [CrossRef]
  49. Evans, D.A.; Rieger, D.L.; Gage, J.R. 13C NMR Chemical Shift Correlations in 1,3-Diol Acetonides. Implications for the Stereochemical Assignment of Propionate-Derived Polyols. Tetrahedron Lett. 1990, 31, 7099–7100. [Google Scholar] [CrossRef]
  50. Morgans, D.J.; Sharpless, K.B.; Traynor, S.G. Epoxy Alcohol Rearrangements: Hydroxyl-Mediated Delivery of Lewis Acid Promoters. J. Am. Chem. Soc. 1981, 103, 462–464. [Google Scholar] [CrossRef]
  51. Maruoka, K.; Hasegawa, M.; Yamamoto, H.; Suzuki, K.; Shimazaki, M.; Tsuchihashi, G. Epoxy Silyl Ether Rearrangements: A New, Stereoselective Approach to the Synthesis of .Beta.-Hydroxy Carbonyl Compounds. J. Am. Chem. Soc. 1986, 108, 3827–3829. [Google Scholar] [CrossRef]
  52. Dávila, W.; Torres, W.; Prieto, J.A. Regioselective Cleavage of 3,4-Epoxy Alcohols with Substituted Alkynylaluminum Reagents: Application to the Stereoselective Synthesis of Polypropionates. Tetrahedron 2007, 63, 8218–8226. [Google Scholar] [CrossRef]
  53. Rodriguez-Berrios, R.; Prieto, A. Synthesis of Anti- and Syn-Hydroxymethyl 1,3-Diol Motifs Based on the Regioselective Cleavage of 2,3-Epoxy Diols Using Organomagnesium and Organoaluminum Reagents: Application to the Polypropionate Synthesis; ACS Spring: Philadelphia, PA, USA, 2020. [Google Scholar]
Figure 1. anti- and syn-hydroxymethyl 1,3-motifs.
Figure 1. anti- and syn-hydroxymethyl 1,3-motifs.
Organics 06 00029 g001
Figure 2. Examples of polypropionates containing hydroxymethyl 1,3-diols.
Figure 2. Examples of polypropionates containing hydroxymethyl 1,3-diols.
Organics 06 00029 g002
Scheme 1. General second-generation epoxide-based methodology employing alkynyl alanes reagents [34,35].
Scheme 1. General second-generation epoxide-based methodology employing alkynyl alanes reagents [34,35].
Organics 06 00029 sch001
Scheme 2. First-generation epoxide-based methodology using Grignard reagents [38].
Scheme 2. First-generation epoxide-based methodology using Grignard reagents [38].
Organics 06 00029 sch002
Scheme 3. Expanded general second-generation epoxide-based methodology employing alkenyl Grignard reagents.
Scheme 3. Expanded general second-generation epoxide-based methodology employing alkenyl Grignard reagents.
Organics 06 00029 sch003
Scheme 4. Preparation of racemic TIPS-moprotected 2,3-epoxy alcohols 1-cis and 1-trans.
Scheme 4. Preparation of racemic TIPS-moprotected 2,3-epoxy alcohols 1-cis and 1-trans.
Organics 06 00029 sch004
Scheme 5. Second-generation two-step synthesis of trans-homoallylic alcohols 3b and 3c [34].
Scheme 5. Second-generation two-step synthesis of trans-homoallylic alcohols 3b and 3c [34].
Organics 06 00029 sch005
Scheme 6. Determination of the regioselectivity by acetonide formation.
Scheme 6. Determination of the regioselectivity by acetonide formation.
Organics 06 00029 sch006
Scheme 7. Conformational models and the average value for the 13C NMR resonances of the five- and six-membered acetonides.
Scheme 7. Conformational models and the average value for the 13C NMR resonances of the five- and six-membered acetonides.
Organics 06 00029 sch007
Scheme 8. Synthesis of the common C5-C10 fragment precursors 13a and 13b of tylosin/mycinamicin I/aldgamacins.
Scheme 8. Synthesis of the common C5-C10 fragment precursors 13a and 13b of tylosin/mycinamicin I/aldgamacins.
Organics 06 00029 sch008
Scheme 9. Studies toward the synthesis of the C11–C14 common fragments of mycinamicins 3b and aldgamacins 14.
Scheme 9. Studies toward the synthesis of the C11–C14 common fragments of mycinamicins 3b and aldgamacins 14.
Organics 06 00029 sch009
Table 1. Preparation of optically active monoprotected 2,3epoxyalcohols (1) via SAE reaction.
Table 1. Preparation of optically active monoprotected 2,3epoxyalcohols (1) via SAE reaction.
Organics 06 00029 i001
EntryAllylic
Alcohol
TartrateProduct D 20 ee% aYield%
Entry 15-ZL-DIPTOrganics 06 00029 i002
(-)-1-cis
−9.98083
Entry 2D-DIPTOrganics 06 00029 i003
(+)-1-cis
+8.48080
Entry 35-EL-DIPTOrganics 06 00029 i004
(-)-1-trans
−10.59491
Entry 4D-DIPTOrganics 06 00029 i005
(+)-1-trans
+13.99480
a Determined by 31P NMR spectroscopy of the Alexakis ester of (-)-1-cis and (+)-1-cis and (-)-1-trans and (+)-1-trans, respectively. b Isolated yield.
Table 2. Cleavage of second-generation TIPS-protected 2,3-epoxy alcohols 1-cis and 1-trans using Cu-catalyzed alkenyl Grignard reagents.
Table 2. Cleavage of second-generation TIPS-protected 2,3-epoxy alcohols 1-cis and 1-trans using Cu-catalyzed alkenyl Grignard reagents.
EntryEpoxideAlkenyl
Grignard a
Major
Product
Regioselectivity bZ/E
Ratio c
%
Yield d
entry 11-cisOrganics 06 00029 i006Organics 06 00029 i0073a95:5>95/566
entry 21-transOrganics 06 00029 i0083b>95:5>95/588
entry 31-cisOrganics 06 00029 i009Organics 06 00029 i0103c>95:534:6642
entry 41-transOrganics 06 00029 i0113d>95:537:6363
entry 51-cisOrganics 06 00029 i012Organics 06 00029 i0133e>95:5N/A81
entry 61-transOrganics 06 00029 i0143f>95:5N/A51
entry 71-cisOrganics 06 00029 i015Organics 06 00029 i0163g>95:5N/A54
entry 81-transOrganics 06 00029 i0173h>95:5N/A46
a The Grignard reagents (6 equiv) were prepared in THF and then transferred to the CuI (1.3 or 0.1 equiv) in ether, −78 °C to rt. b No other regioisomer was detected, except for entry 1. c The Z/E geometry of the 1-bromopropene starting material was determined by NMR spectroscopy. d The yield of major product, except for entries 3 and 4, the yield of the Z/E mixture of isomers.
Table 3. Selected acetonide syntheses and 13C NMR shifts of the ketal and gem-dimethyl carbons.
Table 3. Selected acetonide syntheses and 13C NMR shifts of the ketal and gem-dimethyl carbons.
EntryDiolProductYield%13C (ppm) (CDCl3)
Ketal carbonMethyl carbons
Entry 12aOrganics 06 00029 i01877698.829.4, 19.0
Entry 2Organics 06 00029 i019
6
Organics 06 00029 i020897 a108.826.5, 25.9
Entry 33aOrganics 06 00029 i02197198.729.6, 19.0
a Crude Yield.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rodríguez-Berríos, R.R.; Prieto, J.A. Complementary Synthesis of Anti- and Syn-Hydroxymethyl 1,3-Diols via Regioselective Ring Opening of TIPS-Protected 2,3-Epoxy Alcohols: Toward Polypropionate Fragments. Organics 2025, 6, 29. https://doi.org/10.3390/org6030029

AMA Style

Rodríguez-Berríos RR, Prieto JA. Complementary Synthesis of Anti- and Syn-Hydroxymethyl 1,3-Diols via Regioselective Ring Opening of TIPS-Protected 2,3-Epoxy Alcohols: Toward Polypropionate Fragments. Organics. 2025; 6(3):29. https://doi.org/10.3390/org6030029

Chicago/Turabian Style

Rodríguez-Berríos, Raúl R., and José A. Prieto. 2025. "Complementary Synthesis of Anti- and Syn-Hydroxymethyl 1,3-Diols via Regioselective Ring Opening of TIPS-Protected 2,3-Epoxy Alcohols: Toward Polypropionate Fragments" Organics 6, no. 3: 29. https://doi.org/10.3390/org6030029

APA Style

Rodríguez-Berríos, R. R., & Prieto, J. A. (2025). Complementary Synthesis of Anti- and Syn-Hydroxymethyl 1,3-Diols via Regioselective Ring Opening of TIPS-Protected 2,3-Epoxy Alcohols: Toward Polypropionate Fragments. Organics, 6(3), 29. https://doi.org/10.3390/org6030029

Article Metrics

Back to TopTop